<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Ginseng Res</journal-id><journal-id journal-id-type="iso-abbrev">J Ginseng Res</journal-id><journal-title-group><journal-title>Journal of Ginseng Research</journal-title></journal-title-group><issn pub-type="ppub">1226-8453</issn><issn pub-type="epub">2093-4947</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28123316</article-id><article-id pub-id-type="pmc">5223067</article-id><article-id pub-id-type="publisher-id">S1226-8453(15)00130-X</article-id><article-id pub-id-type="doi">10.1016/j.jgr.2015.12.006</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Animal lectins: potential receptors for ginseng polysaccharides</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Loh</surname><given-names>So Hee</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Jin-Yeon</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Cho</surname><given-names>Eun Hee</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Nah</surname><given-names>Seung-Yeol</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Kang</surname><given-names>Young-Sun</given-names></name><email>kangys1967@naver.com</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff3" ref-type="aff">3</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Biomedical Science and Technology, Institute of Biomedical Science and Technology, Konkuk University, Seoul, Korea</aff><aff id="aff2"><label>2</label>Ginsentology Research Laboratory and Department of Physiology, College of Veterinary Medicine and Bio/Molecular Informatics Center, Konkuk University, Seoul, Korea</aff><aff id="aff3"><label>3</label>Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, Konkuk University, Seoul, Korea</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. Department of Biomedical Science and Technology, Institute of Biomedical Science and Technology, Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea. <email>kangys1967@naver.com</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>17</day><month>12</month><year>2015</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>1</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>17</day><month>12</month><year>2015</year></pub-date><volume>41</volume><issue>1</issue><fpage>1</fpage><lpage>9</lpage><history><date date-type="received"><day>8</day><month>7</month><year>2015</year></date><date date-type="rev-recd"><day>29</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>4</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016, The Korean Society of Ginseng, Published by Elsevier.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder/><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><p><italic>Panax ginseng</italic> Meyer, belonging to the genus <italic>Panax</italic> of the family Araliaceae, is known for its human immune system-related effects, such as immune-boosting effects. Ginseng polysaccharides (GPs) are the responsible ingredient of ginseng in immunomodulation, and are classified as acidic and neutral GPs. Although GPs participate in various immune reactions including the stimulation of immune cells and production of cytokines, the precise function of GPs together with its potential receptor(s) and their signal transduction pathways have remained largely unknown. Animal lectins are carbohydrate-binding proteins that are highly specific for sugar moieties. Among many different biological functions <italic>in&#x000a0;vivo</italic>, animal lectins especially play important roles in the immune system by recognizing carbohydrates that are found exclusively on pathogens or that are inaccessible on host cells. This review summarizes the immunological activities of GPs and the diverse roles of animal lectins in the immune system, suggesting the possibility of animal lectins as the potential receptor candidates of GPs and giving insights into the development of GPs as therapeutic biomaterials for many immunological diseases.</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>animal lectins</kwd><kwd>ginseng polysaccharides</kwd><kwd>immune system</kwd><kwd><italic>Panax ginseng</italic></kwd><kwd>therapeutic biomaterials</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><sec id="sec1.1"><label>1.1</label><title>Ginseng polysaccharides</title><sec id="sec1.1.1"><label>1.1.1</label><title>Ginseng</title><p><italic>Panax ginseng</italic> Meyer is a well-known medicinal plant in the world. The ginseng is a deciduous perennial belonging to the family Araliaceae and genus <italic>Panax</italic>. The genus name of ginseng, <italic>Panax</italic>, is derived from the Greek <italic>pan</italic> (all) <italic>akos</italic> (cure), meaning &#x0201c;cure-all&#x0201d; or &#x0201c;all healing,&#x0201d; which describes the traditional belief that ginseng has properties to heal all aspects of the body. The name ginseng comes from the Chinese words &#x0201c;Jen Sheng,&#x0201d; meaning &#x0201c;man-herb,&#x0201d; because of the humanoid shape of the root or rhizome of the plant, which is the part of the plant most commonly used for extraction <xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>. There are about 13 different species of ginseng which have being identified all over the world. Among them, the most commonly used species of ginseng are Asian ginseng (<italic>P.&#x000a0;ginseng</italic> Meyer, <italic>Renshen</italic>) and American ginseng (<italic>Panax quinquefolius</italic> L., <italic>Xiyangshen</italic>) which all belong to the <italic>Panax</italic> genus of the Araliaceae family <xref rid="bib3" ref-type="bibr">[3]</xref>. Asian ginseng has been used for thousands of years as a tonic to improve overall health, restore the body to balance, help the body to heal itself, and reduce stress <xref rid="bib4" ref-type="bibr">[4]</xref>, and American ginseng has been used by Native Americans for at least hundreds of years <xref rid="bib2" ref-type="bibr">[2]</xref>, <xref rid="bib5" ref-type="bibr">[5]</xref>. Ginseng is prepared and used in several ways as fresh ginseng (sliced and eaten, or brewed in a tea), white ginseng (peeled and dried), red ginseng (peeled, steamed, and dried), extract (tincture or boiled extract), powder, tea, tablet, or capsule <xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>. It has been reported that ginseng exhibits a wide range of beneficial pharmacological effects including immunomodulation, antitumor, antioxidation, antidepression, hypoglycemic, inhibition of gastric lesions, attenuation of leptin-induced cardiac hypertrophy, heart protection against ischemia and reperfusion injury, prevention of glucose-induced oxidative stress, prevention of diabetic nephropathy, retinopathy, and cardiomyopathy <xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib8" ref-type="bibr">[8]</xref>, <xref rid="bib9" ref-type="bibr">[9]</xref>, <xref rid="bib10" ref-type="bibr">[10]</xref>. This broad spectrum of biological activity of ginseng has originated from its multiple bioactive components, namely ginsenosides, polysaccharides (PSs), peptides, polyacetylenic alcohols, and gintonin <xref rid="bib11" ref-type="bibr">[11]</xref>, <xref rid="bib12" ref-type="bibr">[12]</xref>, <xref rid="bib13" ref-type="bibr">[13]</xref>.</p></sec><sec id="sec1.1.2"><label>1.1.2</label><title>The composition of ginseng polysaccharides</title><p>Ginsenosides were considered to be responsible for most of ginseng's pharmacological effects. However, recent studies indicate that ginseng polysaccharides (GPs), one of the active components of ginseng <xref rid="bib14" ref-type="bibr">[14]</xref>, also possess a wide range of biological and pharmaceutical activities, including immune-modulation, antitumor, antiadhesive, antioxidant and hypoglycemic activities <xref rid="bib8" ref-type="bibr">[8]</xref>, <xref rid="bib15" ref-type="bibr">[15]</xref>. Especially, GPs are known for their immunostimulatory effects <xref rid="bib10" ref-type="bibr">[10]</xref>, <xref rid="bib16" ref-type="bibr">[16]</xref>, <xref rid="bib17" ref-type="bibr">[17]</xref> and a major contributor to the bioactivity of herbal medicines, providing great potential applications in food, pharmaceuticals, and other industries. Therefore, GPs were extensively studied for their constituents and chemical structures. GPs are biopolymers formed from a complex chain of monosaccharides rich in <sc>l-</sc>arabinose, <sc>d-</sc>galactose, <sc>l-</sc>rhamnose, <sc>d-</sc>galacturonic acid, <sc>d-</sc>glucuronic acid, and <sc>d-</sc>galactosyl residue linked together through glycosidic bonds, resulting in complex macromolecular architectures <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib18" ref-type="bibr">[18]</xref>, <xref rid="bib19" ref-type="bibr">[19]</xref>. Their molecular weights range from 3500 Da to 2,000,000 Da <xref rid="bib19" ref-type="bibr">[19]</xref>, which contributes to their diverse physicochemical properties and biological activities <xref rid="bib8" ref-type="bibr">[8]</xref>, <xref rid="bib15" ref-type="bibr">[15]</xref>, <xref rid="bib19" ref-type="bibr">[19]</xref>, <xref rid="bib20" ref-type="bibr">[20]</xref>.</p><p>GPs include acidic and neutral PSs. The pharmacological effects of GPs, including immunomodulation, can be attributed to these acidic and neutral PS components <xref rid="bib15" ref-type="bibr">[15]</xref>. While the acidic GPs contain different amounts of uronic acids and neutral sugars <xref rid="bib15" ref-type="bibr">[15]</xref>, <xref rid="bib21" ref-type="bibr">[21]</xref>, the neutral PSs mainly contain different ratios of neutral sugar residues <xref rid="bib3" ref-type="bibr">[3]</xref>. So far, the studies about American GPs have mainly been centered on acidic PSs, resulting in relatively limited research that explores neutral PSs. However, researchers also have interest in neutral PSs of American GPs, because neutral PSs are also one of the important active components in the American ginseng roots. The PSs from ginseng roots have many bioactivities, such as immunomodulation, antitumor, and hypoglycemic activities <xref rid="bib11" ref-type="bibr">[11]</xref>, <xref rid="bib22" ref-type="bibr">[22]</xref>, and contain 60% neutral starch-like PSs, 15% arabinogalactans, and 25% pectins <xref rid="bib20" ref-type="bibr">[20]</xref>. Similarly, the PSs from ginseng leaves are also bioactive, and contain about 70% arabinogalactans and 20% pectins.</p></sec><sec id="sec1.1.3"><label>1.1.3</label><title>The immune functions of GPs</title><p>GPs enable enhancement of the production of cytokines and reactive oxygen species by stimulating macrophages <xref rid="bib23" ref-type="bibr">[23]</xref>, <xref rid="bib24" ref-type="bibr">[24]</xref>. In a recent study, GP was shown to stimulate dendritic cells (DCs) resulting in enhanced production of interferon-&#x003b3; (IFN-&#x003b3;) <xref rid="bib25" ref-type="bibr">[25]</xref>. It was reported that acidic GPs promoted the production of cytotoxic cells against tumors and stimulated macrophages to produce helper types 1 and 2 (Th1 and Th2) cytokines <xref rid="bib26" ref-type="bibr">[26]</xref>, <xref rid="bib27" ref-type="bibr">[27]</xref>. An acidic GP from <italic>P.&#x000a0;ginseng</italic> has been shown to display immunomodulatory effects either in an immunostimulatory or in an immunosuppressive manner, depending on timing of treatments and disease environments <xref rid="bib28" ref-type="bibr">[28]</xref>. This acidic GP was also shown to modulate the antioxidant defense systems such as superoxide dismutase and glutathione peroxidase enzymes, probably via inducing regulatory cytokines <xref rid="bib15" ref-type="bibr">[15]</xref>, <xref rid="bib29" ref-type="bibr">[29]</xref>. Therefore, acidic GPs have been considered as the major bioactive species for immune modulations. Tomoda et&#x000a0;al <xref rid="bib30" ref-type="bibr">[30]</xref> reported that two acidic PSs of <italic>P.&#x000a0;ginseng</italic> enhance the phagocytic activity of macrophages, and Sonoda et&#x000a0;al <xref rid="bib31" ref-type="bibr">[31]</xref> found that an acidic GP of <italic>P.&#x000a0;ginseng</italic> was a potent inducer of interleukin-8 (IL-8) production by human monocytes and THP-1 cells. Shin et&#x000a0;al <xref rid="bib32" ref-type="bibr">[32]</xref> reported that an acidic PS of <italic>P.&#x000a0;ginseng</italic> shows immune modulatory activities via macrophage NO production. Recently, Lemmon et&#x000a0;al <xref rid="bib29" ref-type="bibr">[29]</xref> reported that the immunostimulatory effects of acidic GPs of <italic>P.&#x000a0;quinquefolius</italic> are mediated by PS with a molecular weight higher than 100&#x000a0;kDa. It was reported that acidic GPs promoted the production of cytotoxic cells against tumors and stimulated macrophages to produce helper types 1 and 2 (Th1 and Th2) cytokines <xref rid="bib26" ref-type="bibr">[26]</xref>, <xref rid="bib27" ref-type="bibr">[27]</xref>. Intravenous pretreatment of GP attenuated the production of serum proinflammatory and antiinflammatory cytokines after septic bacterial infection <xref rid="bib33" ref-type="bibr">[33]</xref>.</p><p>In addition, Ginsan, an acidic GP from of <italic>P.&#x000a0;ginseng</italic>, is a well-known medicinal herb and has been shown to have critical effects on immune cells, which shows an immunomodulatory acidic GP from <italic>P.&#x000a0;ginseng</italic>
<xref rid="bib27" ref-type="bibr">[27]</xref>. Kim et&#x000a0;al <xref rid="bib26" ref-type="bibr">[26]</xref> showed that Ginsan induces Th1 cell and macrophage cytokines. Ginsan enhances the production of cytokines and reactive oxygen species by macrophages <xref rid="bib24" ref-type="bibr">[24]</xref> and stimulates the phagocytic activity of macrophages <xref rid="bib23" ref-type="bibr">[23]</xref>. Also, Ginsan induces the maturation of DCs <xref rid="bib25" ref-type="bibr">[25]</xref>, profoundly enhancing the production of IL-12, IL-10, and tumor necrosis factor alpha (TNF-&#x003b1;) by DCs and showed that Ginsan may modulate DC function by altering cytokine levels <xref rid="bib25" ref-type="bibr">[25]</xref>. For neutral GPs, it was reported that neutral GPs of <italic>P. ginseng</italic> stimulate the proliferation of lymphocytes, increase the cytotoxicity of natural killer cell, enhance the phagocytosis and NO production by macrophages, and increase the level of TNF-&#x003b1; in serum <xref rid="bib21" ref-type="bibr">[21]</xref>, <xref rid="bib34" ref-type="bibr">[34]</xref>. Due to these results, many scientists have considered both acidic and neutral GPs as stimulators in the immune system. X. Zhang et al and Kim et al reported that both acidic and neutral GPs of <italic>P. ginseng</italic> (Asian ginseng) may stimulate B cells, T cells and macrophages <xref rid="bib20" ref-type="bibr">[20]</xref>, <xref rid="bib35" ref-type="bibr">[35]</xref>. In addition, they considered the relation of acidic and neutral GPs as the supporter, in which neutral GPs help the enhancement of immunostimulatory effects of acidic GPs. In fact, W. Ni et al reported that neutral GPs of <italic>P. ginseng</italic> enhance macrophage production of NO <xref rid="bib21" ref-type="bibr">[21]</xref>.</p><p>On the contrary to immunostimulatory effects of GPs, recent studies showed that GPs also suppress the proinflammatory responses. Recently, it was reported that a novel neutral PS (PPQN, 3.1&#x000a0;kDa) was isolated from American ginseng roots and could suppress inflammation by inhibiting the secretion of inflammatory-related mediator nitric oxide (NO) and cytokines (TNF-&#x003b1;, IL-6, and IL-1&#x003b2;) compared to Lipopolysaccharide (LPS) treatment, implicating the therapeutic implications of PPQN in inflammatory-related diseases like tumors, atherosclerosis, and so on <xref rid="bib3" ref-type="bibr">[3]</xref>. As an example, one study reported that GPs inhibit immunological responses associated with collagen-induced arthritis <xref rid="bib36" ref-type="bibr">[36]</xref>. Other studies also suggest that CVT-E002, a poly-furanosyl-pyranosyl polysaccharide-rich herbal and unique extract product of the root of American ginseng (<italic>P.&#x000a0;quinquefolium</italic>), suppresses the inflammatory immune responses, reducing the activation of neutrophils <xref rid="bib37" ref-type="bibr">[37]</xref>, inducing the production of IL-2, IFN-&#x003b3;, TNF-&#x003b1;, and IL-6 in spleen <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib19" ref-type="bibr">[19]</xref>, <xref rid="bib38" ref-type="bibr">[38]</xref>, and increasing the proliferation of splenic B lymphocytes, bone marrow, and natural killer cells.</p></sec><sec id="sec1.1.4"><label>1.1.4</label><title>The working mechanisms of GPs in pathogen protection</title><p>Intravenous pretreatment of GP attenuated the production of serum proinflammatory and antiinflammatory cytokines after septic bacterial infection <xref rid="bib33" ref-type="bibr">[33]</xref>. Also, this intravenous pretreatment of GPs in mice enhances macrophage-mediated bactericidal activity by reducing the number of <italic>Staphylococcus aureus</italic> which is present in the spleen, kidney, and blood and exerts a protective effect against infected septic mice by suppressing early acute inflammation <xref rid="bib33" ref-type="bibr">[33]</xref>, <xref rid="bib39" ref-type="bibr">[39]</xref>. In addition, recent studies reported that pretreatment with GP suppressed acute inflammatory responses at an early phase resulting in the enhancement of antimicrobial activities and protection of mice from <italic>Staphylococcus aureus</italic>-induced sepsis as an antiinflammatory function <xref rid="bib33" ref-type="bibr">[33]</xref>, <xref rid="bib39" ref-type="bibr">[39]</xref>. As an example, CVT-E002 has been shown to be effective for preventing acute respiratory illness caused by influenza and respiratory syncytial virus <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib40" ref-type="bibr">[40]</xref>. Another study revealed that intranasal administration of GPs showed a protective effect on influenza viral infection by lowering the levels of inflammatory cytokines (IL-6) and lung viral titers <xref rid="bib28" ref-type="bibr">[28]</xref>. Because GPs were reported to significantly increase the viability of peritoneal macrophage cells <xref rid="bib8" ref-type="bibr">[8]</xref> and ginseng was shown to inhibit degradation of long-lived proteins and to stimulate protein synthesis similar to polypeptide growth factors <xref rid="bib41" ref-type="bibr">[41]</xref>, it was suggested that maintaining the cell viability under the condition of viral infection-induced stress might be an another alternative mechanism for the protective effects of GP.</p><p>It was reported that the recognition and binding of plant PSs by Toll-like receptor 4 (TLR4) leads to the recruitment of various cytoplasmic Toll/IL-1 receptor (TIR) domain-containing adaptors such as myeloid differentiation factor 88 (MyD88), TIR domain-containing adaptor protein (TIRAP), and TIR (Toll/interleukin-1 receptor)-domain-containing adapter-inducing interferon-&#x003b2; (TRIF)-related adaptor molecule (TRAM) <xref rid="bib42" ref-type="bibr">[42]</xref>. It was also shown that the expression of TLRs including TLR2, TLR4, and the adaptor molecule MyD88 is significantly reduced in murine macrophages by GP pretreatment <italic>in&#x000a0;vitro</italic>, which were increased in murine macrophages with the stimulation of <italic>S.&#x000a0;aureus</italic>
<xref rid="bib33" ref-type="bibr">[33]</xref>, <xref rid="bib39" ref-type="bibr">[39]</xref>. On the contrary, Friedl et&#x000a0;al <xref rid="bib16" ref-type="bibr">[16]</xref> and Lemmon et&#x000a0;al <xref rid="bib29" ref-type="bibr">[29]</xref> showed that American GP extracts may mediate the immunostimulatory effect by the inducible nitric oxide synthase (iNOS<bold>)</bold>, mitogen-activated protein kinase (MAPK) kinases such as p38, extracellular signal-regulated kinases 1/2 (ERK1/2), phosphoinositide 3-kinase (PI3K), and nuclear factor kappa B (NF-kB) signaling pathways <xref rid="bib16" ref-type="bibr">[16]</xref>, <xref rid="bib29" ref-type="bibr">[29]</xref>. Therefore, these results suggest that GPs might be associated with the ability of the extract's PS fractions to bind to TLR4 receptor and upregulate or downregulate TLR4 receptor expression, which triggers or inhibits the intracellular signaling cascades and the production of proinflammatory mediators under basal or LPS endotoxic conditions, respectively.</p></sec></sec><sec id="sec1.2"><label>1.2</label><title>Animal lectins</title><sec id="sec1.2.1"><label>1.2.1</label><title>Introduction to animal lectins</title><p>Animal lectins are carbohydrate-binding proteins which are highly variable in their amino acid sequences, widely distributed in microorganisms, viruses, animals and higher plants with different functions, structures, tissue localizations, and carbohydrate-binding specificities <xref rid="bib43" ref-type="bibr">[43]</xref>. Animal lectins were discovered before plant lectins, although many were not recognized as carbohydrate binding proteins for many years after first being reported <xref rid="bib44" ref-type="bibr">[44]</xref>. Although plant and animal lectins do not have homologous primary structures, they have similar preferential binding to carbohydrates <xref rid="bib45" ref-type="bibr">[45]</xref>. Animal lectins are neither immune origin nor catalyst, in contrast to antibodies or enzymes, and are able to detect or bind complex carbohydrate structures specifically through the carbohydrate-recognition domain (CRD) <xref rid="bib46" ref-type="bibr">[46]</xref>, <xref rid="bib47" ref-type="bibr">[47]</xref>. Each animal lectin possess its own CRD which has an identical sequence motif of 115 to 130 amino acid residues and four cysteines that is thoroughly conserved and form two disulfide bonds <xref rid="bib47" ref-type="bibr">[47]</xref>, <xref rid="bib48" ref-type="bibr">[48]</xref>.</p><p>Animal lectin activity is found in association with an astonishing diversity of primary structures <xref rid="bib44" ref-type="bibr">[44]</xref>. At least 12 structural families are known to exist and bind structures other than carbohydrates via protein-protein, protein-lipid or protein-nucleic acid interactions <xref rid="bib44" ref-type="bibr">[44]</xref>. Their roles in glycol-recognition systems include complement activation, cell recognition, cell adhesion, cell migration, cell signaling, and morphogenesis. Moreover, animal lectins are able to take part in defense mechanisms, importantly by recognizing a carbohydrate of pathogens <xref rid="bib47" ref-type="bibr">[47]</xref>, <xref rid="bib48" ref-type="bibr">[48]</xref>. Animal lectins are means of attachment to various cells or viruses via the surface carbohydrate types of the cells to be attached <xref rid="bib49" ref-type="bibr">[49]</xref>. The function in recognition or cell surface interaction of animal lectins has been implicated in direct first-line defense against pathogens <xref rid="bib44" ref-type="bibr">[44]</xref>. For example, the mannose specific receptor, presented on the surface of macrophages, can bind to the infectious organisms which expose mannose-containing glycans on their surface, enabling them to ingest and kill the foreign organisms <xref rid="bib49" ref-type="bibr">[49]</xref>. In addition, animal lectins are involved in cell trafficking, immune regulation, and prevention of autoimmunity <xref rid="bib44" ref-type="bibr">[44]</xref>. Animal lectins are classified into four families based on structure or function. These are the C-type (calcium-requiring) lectins, P-type (mannose-6-phosphate binding) lectins, S-type (galectins) lectins, and I-type (immunoglobulin-like) lectins (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>) <xref rid="bib47" ref-type="bibr">[47]</xref>. Within each family, they have similar sequences and structural properties <xref rid="bib46" ref-type="bibr">[46]</xref>. Recently, other lectin types have been found, including M-type, L-type, chitinase-like, and F-type lectins. In this review, four traditional families of animal lectins are introduced (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>).</p></sec><sec id="sec1.2.2"><label>1.2.2</label><title>C-type lectins</title><p>C-type lectins are endocytic receptors which are mostly expressed by macrophages, DCs, and some endothelial cells. C-type lectins require Ca<sup>2+</sup> for activity and have common sequence motif of 14 invariable and 18 highly conserved amino acid residues <xref rid="bib50" ref-type="bibr">[50]</xref>, <xref rid="bib51" ref-type="bibr">[51]</xref>. As they have multi CRDs, C-type lectins are able to recognize a wide range of carbohydrate-based ligands from endogenous molecules to conserved structures found in bacteria, fungi, virus-infected cells, and parasites called pathogen-associated molecular patterns <xref rid="bib52" ref-type="bibr">[52]</xref>. After recognition, C-type lectins subsequently participate in the uptake for degradation in order to facilitate direct elimination by macrophages or antigen presentation by DCs and macrophages in Major histocompatibility complex (MHC) molecules at the cell surface, resulting in stimulating the adaptive immune system <xref rid="bib53" ref-type="bibr">[53]</xref>, <xref rid="bib54" ref-type="bibr">[54]</xref>. For example, C-type lectins can recognize diverse bacterial pathogens and induce cytokine production and Th17 responses in antibacterial immunity <xref rid="bib55" ref-type="bibr">[55]</xref>, and are critical in systemic infections with pathogens like <italic>Cryptococcus neoformans</italic> in antifungal immunity of Th1 effector cells <xref rid="bib55" ref-type="bibr">[55]</xref>. In addition, they are involved in clearance, homeostasis, and immunomodulation <xref rid="bib56" ref-type="bibr">[56]</xref>. Many C-type lectins play primary roles in immunity. C-type lectins include Dectins, DC-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin (DC-SIGN), SIGN-R1, mannose receptor (MR), Collectin (MBL, SP-A, SP-D) and selectins (L-, P-, E-) (<xref rid="tbl2" ref-type="table">Table&#x000a0;2</xref>).</p></sec></sec><sec id="sec1.3"><label>1.3</label><title>Dectin-1</title><p>Dectin-1 specifically binds to &#x003b2;-1,3 and &#x003b2;-1,6 linked glucans of fungi, plant cell walls, and bacteria, including <italic>Candida albicans</italic>, <italic>Saccharomyces cerevisiae</italic>, <italic>Coccidioides posadasii</italic>, and <italic>Pneumocystis carinii,</italic> but cannot recognize monosaccharides or glucans with other linkages. However, <italic>C.&#x000a0;neoformans</italic>, <italic>Histoplasma capsulatum</italic>, and <italic>Aspergillus fumigatus</italic> are not targeted by Dectin-1, in spite of the presence of &#x003b2;-glucans in their cell wall <xref rid="bib57" ref-type="bibr">[57]</xref>, <xref rid="bib58" ref-type="bibr">[58]</xref>. Dectin-1 plays a primary role in inducing proinflammatory mediators like TNF-&#x003b1; in response to fungal pathogens. Also, Dectin-1 contains an immunotyrosine activation motif within its cytoplasmic tail, helping TLR2 signaling pathway by interaction with the immunotyrosine activation motif of Dectin-1 <xref rid="bib57" ref-type="bibr">[57]</xref>. Signaling by Dectin-1 regulates various cellular responses including phagocytosis and the production of inflammatory cytokines such as IFNs, IL-23, IL-6, and IL-1 <xref rid="bib58" ref-type="bibr">[58]</xref>. Dectin-1 expressed on DCs and macrophages can recognize N-glycans of the surface of tumor cells, following nuclear translocation, and the induction of several genes such as <italic>Inam</italic>, which is known to induce tumor killing by NK cells by hemophilic interactions.</p></sec><sec id="sec1.4"><label>1.4</label><title>DC-SIGN</title><p>DC-SIGN was originally identified as a receptor for intercellular adhesion molecule-3 (ICAM-3) that induces DC-mediated T-cell proliferation <xref rid="bib58" ref-type="bibr">[58]</xref>. It was subsequently unveiled to bind ICAM-2 on vascular endothelial cells, regulating DCs migration through interaction of <italic>N</italic>-linked high mannose structures consisting of from five to nine terminal mannose units <xref rid="bib57" ref-type="bibr">[57]</xref>. DC-SIGN, which is expressed by DCs, decidual and alveolar macrophages facilitates high-affinity binding to high mannose oligosaccharides through tetramerization <xref rid="bib57" ref-type="bibr">[57]</xref>. Mannose-dependent interactions demonstrate the ability of DC-SIGN to bind human immunodeficiency virus (HIV) and various pathogens, including <italic>Mycobacterium tuberculosis</italic>, <italic>C.&#x000a0;albicans</italic>, <italic>Leishmania mexicana</italic>, <italic>A.&#x000a0;fumigatus</italic>, <italic>Helicobacter pylori</italic>, and <italic>Schistosoma mansoni</italic>
<xref rid="bib58" ref-type="bibr">[58]</xref>. For instance, DC-SIGN recognizes mannosylated lipoarabinomannan, which is a mannose-capped glycolipid found in the cell wall of <italic>M.&#x000a0;tuberculosis</italic>. This interaction can induce the secretion of the immunosuppressive cytokine, IL-10, from DCs which expresses DC-SIGN <xref rid="bib57" ref-type="bibr">[57]</xref>. DC-SIGN expression is mostly induced by IL-4, and is downregulated by IFN-&#x003b3;, TGF&#x003b2;, and dexamethasone <xref rid="bib58" ref-type="bibr">[58]</xref>, <xref rid="bib59" ref-type="bibr">[59]</xref>.</p></sec><sec id="sec1.5"><label>1.5</label><title>Eight mouse genes homologous to DC-SIGN (SIGN-Related gene)</title><p>The murine DC-SIGN homologues were reported to help to identify the roles of DC-SIGN in infection and inflammation and to play important roles in bacterial, fungal, and parasitic infections. There are seven mouse genes in the mouse DC-SIGN locus, containing SIGN-R1-5 and SIGN-R7, 8, and a pseudogene, SIGN-R6 <xref rid="bib60" ref-type="bibr">[60]</xref>, <xref rid="bib61" ref-type="bibr">[61]</xref>. The mRNA of three SIGN-R genes encode type II transmembrane proteins (SIGN-R1, 325 amino acids; SIGN-R3, 237 amino acids; SIGN-R4, 208 amino acids), but SIGN-R2 gene only encodes a CRD without a cytosolic domain and a transmembrane domain (SIGN-R2, 178 amino acids) <xref rid="bib62" ref-type="bibr">[62]</xref>. Amino acid sequence similarities between the CRD of human DC-SIGN and the murine homologues are 69% for SIGN-R1, 65% for SIGN-R2, 68% for SIGN-R3, and 70% for SIGN-R4 <xref rid="bib62" ref-type="bibr">[62]</xref>.</p><p>SIGN-R1, a murine homologous transmembrane of the DC-SIGN, is expressed by splenic marginal zone macrophages and peritoneal macrophages <xref rid="bib53" ref-type="bibr">[53]</xref>, <xref rid="bib57" ref-type="bibr">[57]</xref>. Similar to DC-SIGN, SIGN-R1 is essential for the recognition and clearance of <italic>Streptococcus pneumoniae</italic>-derived capsular PSs. Moreover, it can also recognize <italic>C.&#x000a0;albicans</italic>, <italic>M.&#x000a0;tuberculosis</italic>, <italic>S.&#x000a0;pneumoniae</italic> CPS, HIV, and yeast derived zymosan particles in a mannose inhibitable manner <xref rid="bib57" ref-type="bibr">[57]</xref>. SIGN-R1 directly binds to C1q and dominantly regulates the immunoglobulin-independent classical complement pathway for C3 deposition of blood borne <italic>S.&#x000a0;pneumoniae</italic>
<xref rid="bib63" ref-type="bibr">[63]</xref>. In SIGN-R1 deficient mice, C3 deposition is abolished and innate resistance against pneumococci is reduced <xref rid="bib63" ref-type="bibr">[63]</xref>, <xref rid="bib64" ref-type="bibr">[64]</xref>. Also, SIGN-R1 interacts specifically with 2,6 sialylated Fc fragments of immunoglobulins, resulting in the antiinflammatory activity of intravenous immunoglobulin, which has been widely used to treat autoimmune diseases including immune thrombocytopenia, rheumatoid arthritis, and systemic lupus erythematosus <xref rid="bib65" ref-type="bibr">[65]</xref>. SIGN-R3 makes a unique contribution to the protection of the host against bacterial infection such as <italic>M.&#x000a0;tuberculosis</italic>, but SIGN-R1 and SIGN-R5 do not share this function. Although both SIGN-R1 and SIGN-R3 recognize <italic>M.&#x000a0;tuberculosis</italic> and mycobacterial surface glycoconjugates, only SIGN-R3 which is expressed in lung phagocytes can interact with <italic>M.&#x000a0;tuberculosis</italic> via an intracellular tyrosine-based motif that may induce inflammatory cytokine production in collaboration with TLR2 <xref rid="bib60" ref-type="bibr">[60]</xref>.</p></sec><sec id="sec1.6"><label>1.6</label><title>MR and selectins</title><p>MR (CD206) is described in myeloid cells and functions as a viral recognition receptor on the cell membrane for yeast, bacteria, HIV, and a wide variety of pathogens, such as <italic>C.&#x000a0;albicans</italic>, <italic>Leishmania donovani</italic>, <italic>P.&#x000a0;carinii</italic>, <italic>Klebsiella pneumonia</italic>, <italic>Trypanosoma cruzi</italic>, <italic>M.&#x000a0;tuberculosis</italic>
<xref rid="bib66" ref-type="bibr">[66]</xref>, <xref rid="bib67" ref-type="bibr">[67]</xref>, <xref rid="bib68" ref-type="bibr">[68]</xref> and capsular PSs of <italic>S.&#x000a0;pneumoniae</italic> through a mannose-type CRD and pathogen-associated high mannose structures <xref rid="bib69" ref-type="bibr">[69]</xref>. MR which is mainly expressed in immune cells induces uptake and presents mannosylated antigens such as lipoarabinomannan on MHC class II of metallophilic macrophages, resulting in influencing immune responses <xref rid="bib70" ref-type="bibr">[70]</xref>. For instance, the interaction between MR and hepatitis B virus (HBV) surface antigen (HBsAg) enhances viral uptake by DCs, resulting in the impairment in the function of DCs and the ineffective antiviral response of chronic HBV <xref rid="bib71" ref-type="bibr">[71]</xref>. The recognition of viral surface glycoproteins by MR is also beneficial to influenza virus <xref rid="bib72" ref-type="bibr">[72]</xref> and HIV <xref rid="bib73" ref-type="bibr">[73]</xref> invasion into host cells. In addition, MR is able to mediate the clearance of endogenous inflammatory glycoproteins bearing ligands of the mannose-type CRD <xref rid="bib57" ref-type="bibr">[57]</xref>. The expression of MR is upregulated by cytokines like IL-4, IL-13, and IL-10, but IFN induces a downregulatory effect to MR <xref rid="bib58" ref-type="bibr">[58]</xref>.</p><p>Selectins are cell adhesion molecules and have three groups, including E-selectin (endothelial) and P-selectin (platelet) on endothelium, and L-selectin (leukocyte) on leukocytes <xref rid="bib74" ref-type="bibr">[74]</xref>. Selectins play roles in leukocyte recruitment from the bloodstream into sites of inflammation <xref rid="bib55" ref-type="bibr">[55]</xref>, <xref rid="bib74" ref-type="bibr">[74]</xref>. The recruitment of leukocytes proceeds initially by attachment leading to the rolling of leukocytes along endothelial vasculature via selectin-carbohydrate interaction. E-selectin (M.W. 115&#x000a0;kDa) is expressed by endothelial cells after stimulation with activators like TNF-&#x003b1;, IL-1, or bacterial lipopolysaccharide <xref rid="bib55" ref-type="bibr">[55]</xref>. These cytokines also upregulate the expression of P-selectin (M.W. 140&#x000a0;kDa), which is expressed by endothelial cells and platelets <xref rid="bib55" ref-type="bibr">[55]</xref>. Also, P-selectin in released to the cell surface from storage vesicles in endothelial cells and platelets minutes after stimulation by a number of activators, such as thrombin or histamine <xref rid="bib75" ref-type="bibr">[75]</xref>. L-selectin (M.W. 90&#x02013;110&#x000a0;kDa) is expressed by leukocytes and aids in the homing of leukocytes. L-selectin has high expression on na&#x000ef;ve T lymphocytes but, once T lymphocytes are activated, the expression of L-selectin is low or lacking <xref rid="bib45" ref-type="bibr">[45]</xref>. E-, P-, and L-selectin are composed of an N-terminal C-type lectin CRD, an epidermal growth factor-like subunit, a number of short consensus repeat units, a membrane spanning region, and a C-terminal cytoplasmic tail <xref rid="bib76" ref-type="bibr">[76]</xref>. There is approximately 72% homology for analogous selectin CRDs across species, and &#x0223c;52% homology between different selectins within a species <xref rid="bib76" ref-type="bibr">[76]</xref>.</p><sec id="sec1.6.1"><label>1.6.1</label><title>P-type lectins</title><p>P-type lectins are intracellular transmembrane glycoproteins with specificity for mannose-6-phosphate (M6P) to identify and route lysosomal enzymes to the lysosomal compartment (MPR signal) and they have two groups. One is the 43&#x02013;46&#x000a0;kDa cation-dependent M6P receptor (CD-MPR) which requires Ca<sup>2+</sup> for activity and contains single extracellular domain, followed by a single transmembrane domain <xref rid="bib47" ref-type="bibr">[47]</xref>. The other is the 275&#x02013;300&#x000a0;kDa insulin-like growth factor II/cation-independent M6P receptor (IGF-II/CI-MPR) which does not require cation for activity and has a large extracellular domain containing two high-affinity binding sites <xref rid="bib46" ref-type="bibr">[46]</xref>. The CRDs of P-lectins for M6P are located in the extracellular domain of CD-MPR and in extracellular repeats 3 and 9 with high affinity for IGFII/CI-MPR <xref rid="bib46" ref-type="bibr">[46]</xref>. They are similar both in size and in sequence to the repeating units that consisted of short <italic>N</italic>-terminal extracellular domain and <italic>C</italic>-terminal cytoplasmic tail <xref rid="bib77" ref-type="bibr">[77]</xref>. Their function is the intracellular targeting of lysosomal enzymes (lysosomal hydrolases) in the trans-Golgi network vertebrate animals and delivering them to prelysosomal compartments <xref rid="bib78" ref-type="bibr">[78]</xref>. Also, the <italic>C</italic>-terminal cytoplasmic tail of the receptor which targets amino acid sequence plays a role in recognizing signal for transport to the endosomal compartment <xref rid="bib47" ref-type="bibr">[47]</xref>. IGF-II/CI-MPR has the capacity for endocytosis of ligands from the cell surface and serves to turn over IGF by endocytosis, but not CD-MPR <xref rid="bib47" ref-type="bibr">[47]</xref>, <xref rid="bib78" ref-type="bibr">[78]</xref>.</p></sec><sec id="sec1.6.2"><label>1.6.2</label><title>S-lectins</title><p>S-lectins, galectins (from 1 to 14), consist of globular galectin-type CRDs which are specific for &#x003b2;-galactoside ligands and have conserved cysteine residues <xref rid="bib51" ref-type="bibr">[51]</xref>. They are found predominantly in mammals, but not in plants <xref rid="bib46" ref-type="bibr">[46]</xref>. S-lectins have a relatively simple structure and share a highly homologous domain named the S-carbohydrate recognition domain (S-CRD) <xref rid="bib46" ref-type="bibr">[46]</xref>. S-lectins mostly contain multiple sugar-binding sites, as the presence of two type of S-CRD in a single polypeptide or its dimer <xref rid="bib51" ref-type="bibr">[51]</xref>. The function of S-lectins may be to crosslink <italic>N</italic>-acetyllactosamine-containing structures found at cell surfaces or in the extracellular matrix <xref rid="bib79" ref-type="bibr">[79]</xref>. S-Lectins are conserved in unrelated organisms including frogs, birds, and mammals, meaning that &#x003b2;-galactoside binding to lectin may be important biologically <xref rid="bib47" ref-type="bibr">[47]</xref>. Mammalian S-lectins are conserved in eight residues of the S-CRDs and involved in growth regulation, cell adhesion, cell migration, and immune responses <xref rid="bib47" ref-type="bibr">[47]</xref>. For example, galectin-1 mediates cell adhesion and apoptosis, and regulates cellular proliferation. Galectin-3 mediates cell adhesion, regulates inflammation, pre-mRNA splicing, and protects against induced apoptosis. Galectin-4 and galectin-6 have a function in cell&#x02212;cell and cell&#x02212;extracellular matrix crosslinking and galectin-5 is involved in maturation and erythrocyte adhesion <xref rid="bib46" ref-type="bibr">[46]</xref>, <xref rid="bib47" ref-type="bibr">[47]</xref>.</p></sec><sec id="sec1.6.3"><label>1.6.3</label><title>I-type lectins</title><p>I-type lectins are members of the immunoglobulin (Ig) superfamily <xref rid="bib46" ref-type="bibr">[46]</xref>. They share the structural motif, the Ig fold, with Ig-like domains consisted of similar two planes of &#x003b2;-pleated sheets <xref rid="bib80" ref-type="bibr">[80]</xref>. The &#x003b2;-sheets are established about 70&#x02013;110 amino acids, crosslinked by a disulfide bond and contain several hydrogen-bonded antiparallel chains <xref rid="bib51" ref-type="bibr">[51]</xref>. I-type lectins are classified into two domains according to the number and arrangement of &#x003b2;-strands present in the domains <xref rid="bib81" ref-type="bibr">[81]</xref>. One is the amino terminal, extracellular domain, which is similar to the variable region (V-type domain) of IgG and is necessary for sialic acid-dependent binding <xref rid="bib81" ref-type="bibr">[81]</xref>. The other is the constant region (C-type domain) of IgG that has various forms from 1 to 16 <xref rid="bib46" ref-type="bibr">[46]</xref>. I-type lectins function as not only cell adhesion molecules but also growth factor receptors and extracellular matrix molecules <xref rid="bib47" ref-type="bibr">[47]</xref>. The major subclasses of I-type lectins are the sialic acid-binding immunoglobulin superfamily lectins (Siglecs) which contain an homologous <italic>N</italic>-terminal V-type domain with the sialic acid binding site and variable numbers of C-type domains <xref rid="bib46" ref-type="bibr">[46]</xref>. V-type domain and adjacent C-type domains of Siglecs have conserved cysteine residues, resulting in formation of conventional intrasheet and interdomain disulfide bonds <xref rid="bib81" ref-type="bibr">[81]</xref>. The <italic>C</italic>-terminal cytoplasmic tail of most Siglecs has immunoreceptor tyrosine-based motifs in the intracellular domain for signaling events <xref rid="bib81" ref-type="bibr">[81]</xref>. Sialoadhesin found on the surface of macrophages is a member of the Siglecs family <xref rid="bib46" ref-type="bibr">[46]</xref>. It contains a V-type domain and 16 C-type domains <xref rid="bib51" ref-type="bibr">[51]</xref>. The <italic>N</italic>-terminal V-type domain of sialoadhesin enables binding of sialic acid in the ligands of neutrophils, monocytes, NK cells, B cells, and cytotoxic T cells with sialoadhesin <xref rid="bib47" ref-type="bibr">[47]</xref>.</p></sec></sec></sec><sec id="sec2"><label>2</label><title>Animal lectins: potential receptors for GPs</title><p>The diverse roles of botanical PSs have been reported. The antitumor effect of botanical PSs was first known more than 100 years ago when it was found that PSs could alleviate cancer in cancer patients <xref rid="bib82" ref-type="bibr">[82]</xref>. For example, lentinan from <italic>Lentinus edodes</italic> and schizophyllan from <italic>Schizophyllum commune</italic> have antitumor activities and have been used clinically for cancer therapy <xref rid="bib35" ref-type="bibr">[35]</xref>. Through several experiments, it was suggested that the antitumor effects of botanical PSs might be due to potentiation of the response of precursor T cells and macrophages to cytokines produced by lymphocytes after specific recognition of tumor cells <xref rid="bib83" ref-type="bibr">[83]</xref>. Also, botanical PSs of mushroom are known to stimulate natural killer cells, T cells, B cells, and macrophage-dependent immune system responses <xref rid="bib84" ref-type="bibr">[84]</xref>. In addition, arabinogalactans of botanical PSs possess complement fixation activity and induce chemotaxis of human macrophages, T cells, and NK cells <xref rid="bib85" ref-type="bibr">[85]</xref>.</p><p>Although the roles of botanical PSs have been continuously identified, the mechanism of action is not clear yet, because the receptors of botanical PSs remain unknown. However, many scientists have proposed that various pattern recognition receptors (PRRs) might be receptors for botanical PSs. For example, Shao et&#x000a0;al <xref rid="bib86" ref-type="bibr">[86]</xref> suggested that the receptor of PS from the roots of <italic>Astragalus membranaceus</italic>, a medicinal herb, might be MR, TLR4, &#x003b2;-glucan receptor, etc. Schepetkin and Quinn <xref rid="bib87" ref-type="bibr">[87]</xref> also introduced PRRs including TLR4, MR, and dectin-1 as potential receptors of PS polymers. Especially, it was reported that specific glycans of botanical PSs act as immune stimulating agents and effective T cell immune adjuvants <xref rid="bib88" ref-type="bibr">[88]</xref>, <xref rid="bib89" ref-type="bibr">[89]</xref>. Therefore, it was suggested that animal lectins are strong candidates for receptors of botanical PSs among various PRRs, because animal lectins are specialized in recognizing various PSs <xref rid="bib90" ref-type="bibr">[90]</xref>.</p><p>With extensive research for GPs, the roles and chemical composition of GPs have gradually been discovered. For instance, the GPs of <italic>P.&#x000a0;ginseng</italic>, the most common ginseng, are composed of sugars including mannose of 1.2&#x0223c;2.8% by weight, glucose of 64.1&#x0223c;82.8% by weight, galactose of 10.0&#x0223c;26.6% by weight, and arabinose of 0.6&#x0223c;5.4% by weight <xref rid="bib91" ref-type="bibr">[91]</xref>. In addition, CVT-E002, an aqueous extract of the roots of North American ginseng, is composed of 80% poly-furanosyl-pyranosyl-saccharides including rhamnose, glucose, galacturonic acid, galactose, and arabinose <xref rid="bib7" ref-type="bibr">[7]</xref>. Therefore, some of the animal lectins might recognize these glycan structures of GPs, because there are many animal lectins to recognize glycan structures of galactose, glucose, rhamnose, and mannose <xref rid="bib47" ref-type="bibr">[47]</xref>, <xref rid="bib48" ref-type="bibr">[48]</xref>, <xref rid="bib49" ref-type="bibr">[49]</xref>, <xref rid="bib51" ref-type="bibr">[51]</xref>, <xref rid="bib57" ref-type="bibr">[57]</xref>, <xref rid="bib58" ref-type="bibr">[58]</xref>, <xref rid="bib69" ref-type="bibr">[69]</xref>, <xref rid="bib92" ref-type="bibr">[92]</xref>. This could be speculated from the extensive research of specific receptors for botanical PSs in the above section. In particular, clustering of animal lectins might enhance the recognition of GPs, since clustering of simple binding sites in oligomers of the animal lectin polypeptides dramatically increases the affinity for diverse PS structures <xref rid="bib93" ref-type="bibr">[93]</xref>. For example, Byeon et&#x000a0;al <xref rid="bib95" ref-type="bibr">[95]</xref> expected dectin-1 as a receptor of Red ginseng acidic PS, which are known to interact with PS fractions such as &#x003b2;-glucan and zymosan <xref rid="bib94" ref-type="bibr">[94]</xref>, <xref rid="bib95" ref-type="bibr">[95]</xref>.</p></sec><sec id="sec3"><label>3</label><title>Concluding remarks</title><p>GPs which are isolated from a variety of traditional medicinal ginsengs involved in various innate immune responses, such as the production of cytokines and maturation of DCs <italic>in&#x000a0;vivo</italic> and <italic>in&#x000a0;vitro</italic>, show potential to be immunomodulators with wide applications <xref rid="bib23" ref-type="bibr">[23]</xref>, <xref rid="bib24" ref-type="bibr">[24]</xref>, <xref rid="bib25" ref-type="bibr">[25]</xref>. In addition, most of them are relatively nontoxic and do not cause significant side effects, which are major problems of immunomodulatory bacterial PSs and synthetic compounds. Thus, GPs are becoming ideal candidates for therapeutics for collagen-induced arthritis, inflammation, and inflammatory-related diseases like tumors, atherosclerosis, and so on <xref rid="bib3" ref-type="bibr">[3]</xref>, <xref rid="bib27" ref-type="bibr">[27]</xref>, <xref rid="bib28" ref-type="bibr">[28]</xref>, <xref rid="bib32" ref-type="bibr">[32]</xref>, <xref rid="bib36" ref-type="bibr">[36]</xref>. Although the roles of GPs are being continuously identified, the detailed mechanisms of actions are not clear yet, because the receptors of GPs remain largely unknown. Therefore, it is tempting to speculate that animal lectins could be strong candidates of receptors for GPs. To prove this possibility, extensive researches for the specific structures of GPs and the interaction between GPs and animal lectins is required in the near future. By unraveling receptors of GPs <italic>in&#x000a0;vivo</italic>, it is possible to specifically understand the detailed mechanism for the immunological activities of GPs in the immune system, giving insights into the development of GPs as therapeutic biomaterials for many immunological diseases.</p></sec><sec id="sec4"><title>Conflicts of interest</title><p>The authors declare no conflicts of interest.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Hofseth</surname><given-names>L.J.</given-names></name><name><surname>Wargovich</surname><given-names>M.J.</given-names></name></person-group><article-title>Inflammation, cancer, and targets of ginseng</article-title><source>J&#x000a0;Nutr</source><volume>137</volume><year>2007</year><fpage>183S</fpage><lpage>185S</lpage><pub-id pub-id-type="pmid">17182823</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Angelova</surname><given-names>N.</given-names></name><name><surname>Kong</surname><given-names>H.W.</given-names></name><name><surname>van der Heijden</surname><given-names>R.</given-names></name><name><surname>Yang</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>Y.H.</given-names></name><name><surname>Kim</surname><given-names>H.K.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Hankemeier</surname><given-names>T.</given-names></name><name><surname>van der Greef</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>G.</given-names></name></person-group><article-title>Recent methodology in the phytochemical analysis of ginseng</article-title><source>Phytochem Anal</source><volume>19</volume><year>2008</year><fpage>2</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">18058794</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Yao</surname><given-names>Y.</given-names></name><name><surname>Lui</surname><given-names>E.M.</given-names></name><name><surname>Ren</surname><given-names>G.</given-names></name></person-group><article-title>Structural and anti-inflammatory characterization of a novel neutral polysaccharide from North American ginseng (<italic>Panax quinquefolius</italic>)</article-title><source>Int J Biol Macromol</source><volume>74C</volume><year>2014</year><fpage>12</fpage><lpage>17</lpage></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>Xiu-zhen</given-names></name><name><surname>Wang</surname><given-names>Bing-qing</given-names></name><name><surname>Zhi</surname><given-names>Yuan</given-names></name><name><surname>Wei</surname><given-names>Ning-ning</given-names></name><name><surname>Zhang</surname><given-names>Xu</given-names></name><name><surname>Li</surname><given-names>Shan-shan</given-names></name><name><surname>Tai</surname><given-names>Gui-hua</given-names></name><name><surname>Zhou</surname><given-names>Yi-fa</given-names></name><name><surname>Zhao</surname><given-names>Ji-ming</given-names></name></person-group><article-title>Total fractionation and analysis of polysaccharides from leaves of <italic>Panax ginseng</italic> C.A. Meyer</article-title><source>Chem Res Chniese Universities</source><volume>26</volume><year>2010</year><fpage>230</fpage><lpage>234</lpage></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Borchers</surname><given-names>A.T.</given-names></name><name><surname>Keen</surname><given-names>C.L.</given-names></name><name><surname>Stern</surname><given-names>J.S.</given-names></name><name><surname>Gershwin</surname><given-names>M.E.</given-names></name></person-group><article-title>Inflammation and native American medicine: the role of botanicals</article-title><source>Am J Clin Nutr</source><volume>72</volume><year>2000</year><fpage>339</fpage><lpage>347</lpage><pub-id pub-id-type="pmid">10919925</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>D.C.</given-names></name><name><surname>Yang</surname><given-names>C.L.</given-names></name><name><surname>Chik</surname><given-names>S.C.</given-names></name><name><surname>Li</surname><given-names>J.C.</given-names></name><name><surname>Rong</surname><given-names>J.H.</given-names></name><name><surname>Chan</surname><given-names>G.C.</given-names></name><name><surname>Lau</surname><given-names>A.S.</given-names></name></person-group><article-title>Bioactivity-guided identification and cell signaling technology to delineate the immunomodulatory effects of <italic>Panax ginseng</italic> on human promonocytic U937 cells</article-title><source>J&#x000a0;Transl Med</source><volume>7</volume><year>2009</year><fpage>34</fpage><pub-id pub-id-type="pmid">19442267</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Biondo</surname><given-names>P.D.</given-names></name><name><surname>Goruk</surname><given-names>S.</given-names></name><name><surname>Ruth</surname><given-names>M.R.</given-names></name><name><surname>Ruth</surname><given-names>M.R.</given-names></name><name><surname>O'Connell</surname><given-names>E.</given-names></name><name><surname>Field</surname><given-names>C.J.</given-names></name></person-group><article-title>Effect of CVT-E002 (COLD-fX) versus a ginsenoside extract on systemic and gut-associated immune function</article-title><source>Int Immunopharmacol</source><volume>8</volume><year>2008</year><fpage>1134</fpage><lpage>1142</lpage><pub-id pub-id-type="pmid">18550018</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>T.S.</given-names></name><name><surname>Na</surname><given-names>K.</given-names></name><name><surname>Choi</surname><given-names>E.M.</given-names></name><name><surname>Chung</surname><given-names>J.Y.</given-names></name><name><surname>Hwang</surname><given-names>J.K.</given-names></name></person-group><article-title>Immunomodulating activities of polysaccharides isolated from <italic>Panax ginseng</italic></article-title><source>J&#x000a0;Med Food</source><volume>7</volume><year>2004</year><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15117545</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X.B.</given-names></name><name><surname>Matsumoto</surname><given-names>T.</given-names></name><name><surname>Kiyohara</surname><given-names>H.</given-names></name><name><surname>Hirano</surname><given-names>M.</given-names></name><name><surname>Yamada</surname><given-names>H.</given-names></name></person-group><article-title>Cytoprotective activity of pectic polysaccharides from the root of <italic>Panax ginseng</italic></article-title><source>J&#x000a0;Ethnopharmacol</source><volume>31</volume><year>1991</year><fpage>101</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">2030589</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Assinewe</surname><given-names>V.A.</given-names></name><name><surname>Amason</surname><given-names>J.T.</given-names></name><name><surname>Aubry</surname><given-names>A.</given-names></name><name><surname>Mullin</surname><given-names>J.</given-names></name><name><surname>Lemaire</surname><given-names>I.</given-names></name></person-group><article-title>Extractable polysaccharides of <italic>Panax quinquefolius</italic> L. (North American ginseng) root stimulate TNFalpha production by alveolar macrophages</article-title><source>Phytomedicine</source><volume>9</volume><year>2002</year><fpage>398</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">12222658</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Attele</surname><given-names>A.S.</given-names></name><name><surname>Wu</surname><given-names>J.A.</given-names></name><name><surname>Yuan</surname><given-names>C.S.</given-names></name></person-group><article-title>Ginseng pharmacology: multiple constituents and multiple actions</article-title><source>Biochem Pharmacol</source><volume>58</volume><year>1999</year><fpage>1685</fpage><lpage>1693</lpage><pub-id pub-id-type="pmid">10571242</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Kitts</surname><given-names>D.</given-names></name><name><surname>Hu</surname><given-names>C.</given-names></name></person-group><article-title>Efficacy and safety of ginseng</article-title><source>Public Health Nutr</source><volume>3</volume><year>2000</year><fpage>473</fpage><lpage>485</lpage><pub-id pub-id-type="pmid">11276295</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>S.H.</given-names></name><name><surname>Shin</surname><given-names>T.J.</given-names></name><name><surname>Choi</surname><given-names>S.H.</given-names></name><name><surname>Cho</surname><given-names>H.J.</given-names></name><name><surname>Lee</surname><given-names>B.H.</given-names></name><name><surname>Pyo</surname><given-names>M.K.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Kang</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>H.J.</given-names></name><name><surname>Park</surname><given-names>C.W.</given-names></name></person-group><article-title>Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity</article-title><source>Mol Cells</source><volume>33</volume><year>2012</year><fpage>151</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">22286231</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>T.-K.</given-names></name></person-group><article-title><italic>Panax ginseng</italic>&#x02013;a non-organ-specific cancer preventive?</article-title><source>Lancet Oncol</source><volume>2</volume><year>2001</year><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">11905620</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y.</given-names></name></person-group><article-title>Structure and biological activities of the polysaccharides from the leaves, roots and fruits of <italic>Panax ginseng</italic> C.A. Meyer: an overview</article-title><source>Carbohydr Polym</source><volume>85</volume><year>2011</year><fpage>490</fpage><lpage>499</lpage></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Friedl</surname><given-names>R.</given-names></name><name><surname>Moeslinger</surname><given-names>T.</given-names></name><name><surname>Kopp</surname><given-names>B.</given-names></name><name><surname>Spieckermann</surname><given-names>P.G.</given-names></name></person-group><article-title>Stimulation of nitric oxide synthesis by the aqueous extract of <italic>Panax ginseng</italic> root in RAW 264.7 cells</article-title><source>Br J Pharmacol</source><volume>134</volume><year>2001</year><fpage>1663</fpage><lpage>1670</lpage><pub-id pub-id-type="pmid">11739242</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>H.S.</given-names></name><name><surname>Kim</surname><given-names>K.H.</given-names></name><name><surname>Sohn</surname><given-names>E.</given-names></name><name><surname>Park</surname><given-names>J.D.</given-names></name><name><surname>Kim</surname><given-names>B.O.</given-names></name><name><surname>Moon</surname><given-names>E.Y.</given-names></name><name><surname>Rhee</surname><given-names>D.K.</given-names></name><name><surname>Pyo</surname><given-names>S.</given-names></name></person-group><article-title>Red ginseng acidic polysaccharide (RGAP) in combination with IFN-gamma results in enhanced macrophage function through activation of the NF-kappaB pathway</article-title><source>Biosci Biotechnol Biochem</source><volume>72</volume><year>2008</year><fpage>1817</fpage><lpage>1825</lpage><pub-id pub-id-type="pmid">18603775</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>R.</given-names></name></person-group><article-title>Bioactive polysaccharides from plants</article-title><source>Phytochemistry</source><volume>28</volume><year>1989</year><fpage>2877</fpage><lpage>2883</lpage></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Guilbert</surname><given-names>L.J.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Pang</surname><given-names>P.</given-names></name><name><surname>Basu</surname><given-names>T.K.</given-names></name><name><surname>Shan</surname><given-names>J.J.</given-names></name></person-group><article-title>A&#x000a0;proprietary extract from North American ginseng (<italic>Panax quinquefolium</italic>) enhances IL-2 and IFN-gamma productions in murine spleen cells induced by Con-A</article-title><source>Int Immunopharmacol</source><volume>4</volume><year>2004</year><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">14996422</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Zhang</given-names></name><name><surname>Li</surname><given-names>Yu</given-names></name><name><surname>Hongtao</surname><given-names>Bi</given-names></name><name><surname>Xianhua</surname><given-names>Li</given-names></name><name><surname>Weihua</surname><given-names>Ni</given-names></name><name><surname>Han</surname><given-names>Han</given-names></name><name><surname>Nan</surname><given-names>Li</given-names></name><name><surname>Bingqing</surname><given-names>Wang</given-names></name><name><surname>Yifa</surname><given-names>Zhou</given-names></name><name><surname>Guihua</surname><given-names>Tai</given-names></name></person-group><article-title>Total fractionation and characterization of the water-soluble polysaccharides isolated from <italic>Panax ginseng</italic> CA Meyer</article-title><source>Carbohydr Polym</source><volume>77</volume><year>2009</year><fpage>544</fpage><lpage>552</lpage></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Han</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Tai</surname><given-names>G.</given-names></name></person-group><article-title>Antitumor activities and immunomodulatory effects of ginseng neutral polysaccharides in combination with 5-fluorouracil</article-title><source>J&#x000a0;Med Food</source><volume>13</volume><year>2010</year><fpage>270</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">20132044</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Shim</surname><given-names>J.S.</given-names></name><name><surname>Lee</surname><given-names>J.S.</given-names></name><name><surname>Kim</surname><given-names>M.K.</given-names></name><name><surname>Chung</surname><given-names>M.S.</given-names></name><name><surname>Kim</surname><given-names>K.H.</given-names></name></person-group><article-title>Pectin-like acidic polysaccharide from <italic>Panax ginseng</italic> with selective antiadhesive activity against pathogenic bacteria</article-title><source>Carbohydr Res</source><volume>341</volume><year>2006</year><fpage>1154</fpage><lpage>1163</lpage><pub-id pub-id-type="pmid">16643869</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Song</surname><given-names>J.Y.</given-names></name><name><surname>Han</surname><given-names>S.K.</given-names></name><name><surname>Son</surname><given-names>E.H.</given-names></name><name><surname>Pyo</surname><given-names>S.N.</given-names></name><name><surname>Yun</surname><given-names>Y.S.</given-names></name><name><surname>Yi</surname><given-names>S.Y.</given-names></name></person-group><article-title>Induction of secretory and tumoricidal activities in peritoneal macrophages by ginsan</article-title><source>Int Immunopharmacol</source><volume>2</volume><year>2002</year><fpage>857</fpage><lpage>865</lpage><pub-id pub-id-type="pmid">12188027</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>J.Y.</given-names></name><name><surname>Song</surname><given-names>J.Y.</given-names></name><name><surname>Yun</surname><given-names>Y.S.</given-names></name><name><surname>Yang</surname><given-names>H.O.</given-names></name><name><surname>Rhee</surname><given-names>D.K.</given-names></name><name><surname>Pyo</surname><given-names>S.</given-names></name></person-group><article-title>Immunostimulating effects of acidic polysaccharides extract of <italic>Panax ginseng</italic> on macrophage function</article-title><source>Immunopharmacol Immunotoxicol</source><volume>24</volume><year>2002</year><fpage>469</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">12375741</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M.H.</given-names></name><name><surname>Byon</surname><given-names>Y.Y.</given-names></name><name><surname>Ko</surname><given-names>E.J.</given-names></name><name><surname>Song</surname><given-names>J.Y.</given-names></name><name><surname>Yun</surname><given-names>Y.S.</given-names></name><name><surname>Shin</surname><given-names>T.</given-names></name><name><surname>Joo</surname><given-names>H.G.</given-names></name></person-group><article-title>Immunomodulatory activity of ginsan, a polysaccharide of <italic>Panax ginseng</italic>, on dendritic cells</article-title><source>Korean J Physiol Pharmacol</source><volume>13</volume><year>2009</year><fpage>169</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">19885033</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.H.</given-names></name><name><surname>Lee</surname><given-names>Y.S.</given-names></name><name><surname>Jung</surname><given-names>I.S.</given-names></name><name><surname>Park</surname><given-names>S.Y.</given-names></name><name><surname>Chung</surname><given-names>H.Y.</given-names></name><name><surname>Lee</surname><given-names>I.R.</given-names></name><name><surname>Yun</surname><given-names>Y.S.</given-names></name></person-group><article-title>Acidic polysaccharide from <italic>Panax ginseng</italic>, ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2</article-title><source>Planta Med</source><volume>64</volume><year>1998</year><fpage>110</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">9525101</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.S.</given-names></name><name><surname>Chung</surname><given-names>I.S.</given-names></name><name><surname>Lee</surname><given-names>I.R.</given-names></name><name><surname>Kim</surname><given-names>K.H.</given-names></name><name><surname>Hong</surname><given-names>W.S.</given-names></name><name><surname>Yun</surname><given-names>Y.S.</given-names></name></person-group><article-title>Activation of multiple effector pathways of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from <italic>Panax ginseng</italic></article-title><source>Anticancer Res</source><volume>17</volume><year>1997</year><fpage>323</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">9066672</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>D.G.</given-names></name><name><surname>Kim</surname><given-names>M.C.</given-names></name><name><surname>Park</surname><given-names>M.K.</given-names></name><name><surname>Park</surname><given-names>K.M.</given-names></name><name><surname>Quan</surname><given-names>F.S.</given-names></name><name><surname>Song</surname><given-names>J.M.</given-names></name><name><surname>Wee</surname><given-names>J.J.</given-names></name><name><surname>Wang</surname><given-names>B.Z.</given-names></name><name><surname>Cho</surname><given-names>Y.K.</given-names></name><name><surname>Compans</surname><given-names>R.W.</given-names></name></person-group><article-title>Protective effect of ginseng polysaccharides on influenza viral infection</article-title><source>PLoS One</source><volume>7</volume><year>2012</year><fpage>e33678</fpage><pub-id pub-id-type="pmid">22442708</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Lemmon</surname><given-names>H.R.</given-names></name><name><surname>Sham</surname><given-names>J.</given-names></name><name><surname>Chau</surname><given-names>L.A.</given-names></name><name><surname>Madrenas</surname><given-names>J.</given-names></name></person-group><article-title>High molecular weight polysaccharides are key immunomodulators in North American ginseng extracts: characterization of the ginseng genetic signature in primary human immune cells</article-title><source>J&#x000a0;Ethnopharmacol</source><volume>142</volume><year>2012</year><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">22521964</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Tomoda</surname><given-names>M.</given-names></name><name><surname>Hirabayashi</surname><given-names>K.</given-names></name><name><surname>Shimizu</surname><given-names>N.</given-names></name><name><surname>Gonda</surname><given-names>R.</given-names></name><name><surname>Ohara</surname><given-names>N.</given-names></name><name><surname>Takada</surname><given-names>K.</given-names></name></person-group><article-title>Characterization of two novel polysaccharides having immunological activities from the root of <italic>Panax ginseng</italic></article-title><source>Biol Pharm Bull</source><volume>16</volume><year>1993</year><fpage>1087</fpage><lpage>1090</lpage><pub-id pub-id-type="pmid">8312860</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Sonoda</surname><given-names>Y.</given-names></name><name><surname>Kasahara</surname><given-names>T.</given-names></name><name><surname>Mukaida</surname><given-names>N.</given-names></name><name><surname>Shimizu</surname><given-names>N.</given-names></name><name><surname>Tomoda</surname><given-names>M.</given-names></name><name><surname>Takeda</surname><given-names>T.</given-names></name></person-group><article-title>Stimulation of interleukin-8 production by acidic polysaccharides from the root of <italic>Panax ginseng</italic></article-title><source>Immunopharmacology</source><volume>38</volume><year>1998</year><fpage>287</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">9506829</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name><name><surname>Kwak</surname><given-names>Y.S.</given-names></name><name><surname>Song</surname><given-names>Y.B.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name><name><surname>Park</surname><given-names>J.D.</given-names></name></person-group><article-title>Enhancement of antitumor effects of paclitaxel (taxol) in combination with red ginseng acidic polysaccharide (RGAP)</article-title><source>Planta Med</source><volume>70</volume><year>2004</year><fpage>1033</fpage><lpage>1038</lpage><pub-id pub-id-type="pmid">15549658</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>J.Y.</given-names></name><name><surname>Choi</surname><given-names>I.S.</given-names></name><name><surname>Shim</surname><given-names>J.Y.</given-names></name><name><surname>Yun</surname><given-names>E.K.</given-names></name><name><surname>Yun</surname><given-names>Y.S.</given-names></name><name><surname>Jeong</surname><given-names>G.</given-names></name><name><surname>Song</surname><given-names>J.Y.</given-names></name></person-group><article-title>The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting Toll-like receptor-mediated inflammatory signals</article-title><source>Eur J Immunol</source><volume>36</volume><year>2006</year><fpage>37</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">16342327</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>V.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Oroudjev</surname><given-names>E.</given-names></name><name><surname>Lee</surname><given-names>C.J.</given-names></name><name><surname>Marasigan</surname><given-names>C.</given-names></name><name><surname>Wilson</surname><given-names>L.</given-names></name><name><surname>Ayoub</surname><given-names>G.</given-names></name></person-group><article-title>Cytotoxic effects of bilberry extract on MCF7-GFP-tubulin breast cancer cells</article-title><source>J&#x000a0;Med Food</source><volume>13</volume><year>2010</year><fpage>278</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">20132040</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.S.</given-names></name><name><surname>Kang</surname><given-names>K.S.</given-names></name><name><surname>Kim</surname><given-names>S.I.</given-names></name></person-group><article-title>Study on antitumor and immunomodulating activities of polysaccharide fractions from <italic>Panax ginseng</italic>: Comparison of effects of neutral and acidic polysaccharide fraction</article-title><source>Arch Pharm Res</source><volume>13</volume><year>1990</year><fpage>330</fpage><lpage>337</lpage></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H.Y.</given-names></name><name><surname>Zhang</surname><given-names>W.D.</given-names></name><name><surname>Xiao</surname><given-names>C.</given-names></name><name><surname>Lu</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>S.H.</given-names></name><name><surname>He</surname><given-names>X.J.</given-names></name><name><surname>Li</surname><given-names>X.B.</given-names></name><name><surname>Chen</surname><given-names>S.L.</given-names></name><name><surname>Yang</surname><given-names>D.J.</given-names></name><name><surname>Chan</surname><given-names>A.S.C.</given-names></name></person-group><article-title>Effect of ginseng polysaccharide on TNF-alpha and IFN-gamma produced by enteric mucosal lymphocytes in collagen induced arthritic rats</article-title><source>J&#x000a0;Med Plant Res</source><volume>5</volume><year>2011</year><fpage>1536</fpage><lpage>1542</lpage></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Pillai</surname><given-names>R.</given-names></name><name><surname>Lacy</surname><given-names>P.</given-names></name></person-group><article-title>Inhibition of neutrophil respiratory burst and degranulation responses by CVT-E002, the main active ingredient in COLD-FX</article-title><source>Allergy Asthma Clin Immunol</source><volume>7</volume><year>2011</year><fpage>A31</fpage></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Guilbert</surname><given-names>L.J.</given-names></name><name><surname>Ling</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Pang</surname><given-names>P.</given-names></name><name><surname>Shan</surname><given-names>J.J.</given-names></name></person-group><article-title>Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (<italic>Panax quinquefolium</italic>)</article-title><source>J&#x000a0;Pharm Pharmacol</source><volume>53</volume><year>2001</year><fpage>1515</fpage><lpage>1523</lpage><pub-id pub-id-type="pmid">11732754</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>J.Y.</given-names></name><name><surname>Song</surname><given-names>J.Y.</given-names></name><name><surname>Yun</surname><given-names>Y.S.</given-names></name><name><surname>Jeong</surname><given-names>G.</given-names></name><name><surname>Choi</surname><given-names>I.S.</given-names></name></person-group><article-title>Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan</article-title><source>FEMS Immunol Med Microbiol</source><volume>46</volume><year>2006</year><fpage>187</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">16487300</pub-id></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>McElhaney</surname><given-names>J.E.</given-names></name><name><surname>Gravenstein</surname><given-names>S.</given-names></name><name><surname>Cole</surname><given-names>S.K.</given-names></name><name><surname>Davidson</surname><given-names>E.</given-names></name><name><surname>O'Neill</surname><given-names>D.</given-names></name><name><surname>Petitjean</surname><given-names>S.</given-names></name><name><surname>Rumble</surname><given-names>B.</given-names></name><name><surname>Shan</surname><given-names>J.J.</given-names></name></person-group><article-title>A&#x000a0;placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults</article-title><source>J&#x000a0;Am Geriatr Soc</source><volume>52</volume><year>2004</year><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">14687309</pub-id></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Z.Q.</given-names></name><name><surname>Dice</surname><given-names>J.F.</given-names></name></person-group><article-title>Ginseng extract inhibits protein degradation and stimulates protein synthesis in human fibroblasts</article-title><source>Biochem Biophys Res Commun</source><volume>126</volume><year>1985</year><fpage>636</fpage><lpage>640</lpage><pub-id pub-id-type="pmid">3882091</pub-id></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>H.</given-names></name><name><surname>Kawai</surname><given-names>T.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name></person-group><article-title>Toll-like receptors and innate immunity</article-title><source>Biochem Biophys Res Commun</source><volume>388</volume><year>2009</year><fpage>621</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">19686699</pub-id></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="book" id="sref43"><person-group person-group-type="author"><name><surname>Etzler</surname><given-names>M.E.</given-names></name></person-group><chapter-title>Distribution and function to plant lectins</chapter-title><source>The lectins</source><year>2012</year><publisher-name>Academic Press</publisher-name><publisher-loc>San Diego</publisher-loc><fpage>371</fpage><lpage>436</lpage></element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Kilpatrick</surname><given-names>D.C.</given-names></name></person-group><article-title>Animal lectins: a historical introduction and overview</article-title><source>Biochim Biophys Acta</source><volume>1572</volume><year>2002</year><fpage>187</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">12223269</pub-id></element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Ghazarian</surname><given-names>H.</given-names></name><name><surname>Idoni</surname><given-names>B.</given-names></name><name><surname>Oppenheimer</surname><given-names>S.B.</given-names></name></person-group><article-title>A&#x000a0;glycobiology review: carbohydrates, lectins and implications in cancer therapeutics</article-title><source>Acta Histochem</source><volume>113</volume><year>2011</year><fpage>236</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">20199800</pub-id></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Sharon</surname><given-names>H.</given-names></name><name><surname>La</surname><given-names>N.</given-names></name></person-group><article-title>Lectins:&#x02009; carbohydrate-specific proteins that mediate cellular recognition</article-title><source>Chem Rev</source><volume>98</volume><year>1998</year><fpage>637</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">11848911</pub-id></element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>K.</given-names></name><name><surname>David</surname><given-names>Evers</given-names></name><name><surname>Rice</surname><given-names>Kevin G.</given-names></name></person-group><article-title>Structure and function of mammalian carbohydrate-lectin interactions</article-title><source>Glycoscience</source><year>2008</year><fpage>2445</fpage><lpage>2482</lpage></element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>J.</given-names></name><name><surname>Nakamoto</surname><given-names>C.</given-names></name><name><surname>Fujiwara</surname><given-names>S.</given-names></name><name><surname>Yubisui</surname><given-names>T.</given-names></name><name><surname>Kawamura</surname><given-names>K.</given-names></name></person-group><article-title>A&#x000a0;novel C-type lectin regulating cell growth, cell adhesion and cell differentiation of the multipotent epithelium in budding tunicates</article-title><source>Development</source><volume>128</volume><year>2001</year><fpage>3339</fpage><lpage>3347</lpage><pub-id pub-id-type="pmid">11546750</pub-id></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>H.</given-names></name></person-group><article-title>Insight of lectins&#x02013;A review</article-title><source>Int J Sci Eng Res</source><volume>3</volume><year>2012</year><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="bib50"><label>50</label><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>Drickamer</surname><given-names>K.</given-names></name><name><surname>Taylor</surname><given-names>M.E.</given-names></name></person-group><article-title>Biology of animal lectins</article-title><source>Annu Rev Cell Biol</source><volume>9</volume><year>1993</year><fpage>237</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">8280461</pub-id></element-citation></ref><ref id="bib51"><label>51</label><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Gabius</surname><given-names>H.J.</given-names></name></person-group><article-title>Animal lectins</article-title><source>Eur J Biochem</source><volume>243</volume><year>1997</year><fpage>543</fpage><lpage>576</lpage><pub-id pub-id-type="pmid">9057819</pub-id></element-citation></ref><ref id="bib52"><label>52</label><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>L.M.</given-names></name></person-group><article-title>The C-type lectin receptor CLECSF8 (CLEC4D) is expressed by myeloid cells and triggers cellular activation through syk kinase</article-title><source>J&#x000a0;Biol Chem</source><volume>287</volume><year>2012</year><fpage>25964</fpage><lpage>25974</lpage><pub-id pub-id-type="pmid">22689578</pub-id></element-citation></ref><ref id="bib53"><label>53</label><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Cambi</surname><given-names>A.</given-names></name></person-group><article-title>How C-type lectins detect pathogens</article-title><source>Cell Microbiol</source><volume>7</volume><year>2005</year><fpage>481</fpage><lpage>488</lpage><pub-id pub-id-type="pmid">15760448</pub-id></element-citation></ref><ref id="bib54"><label>54</label><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Figdor</surname><given-names>A.</given-names></name><name><surname>Ca</surname><given-names>C.G.</given-names></name></person-group><article-title>Dual function of C-type lectin-like receptors in the immune system</article-title><source>Curr Opin Cell Biol</source><volume>15</volume><year>2003</year><fpage>539</fpage><lpage>546</lpage><pub-id pub-id-type="pmid">14519388</pub-id></element-citation></ref><ref id="bib55"><label>55</label><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>Dambuza</surname><given-names>I.M.</given-names></name><name><surname>Brown</surname><given-names>G.D.</given-names></name></person-group><article-title>C-type lectins in immunity: recent developments</article-title><source>Curr Opin Immunol</source><volume>32</volume><year>2015</year><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">25553393</pub-id></element-citation></ref><ref id="bib56"><label>56</label><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group><article-title>Pattern recognition receptors: doubling up for the innate immune response</article-title><source>Cell</source><volume>111</volume><year>2002</year><fpage>927</fpage><lpage>930</lpage><pub-id pub-id-type="pmid">12507420</pub-id></element-citation></ref><ref id="bib57"><label>57</label><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>McGreal</surname><given-names>E.P.</given-names></name><name><surname>Martinez-Pomares</surname><given-names>L.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group><article-title>Divergent roles for C-type lectins expressed by cells of the innate immune system</article-title><source>Mol Immunol</source><volume>41</volume><year>2004</year><fpage>1109</fpage><lpage>1121</lpage><pub-id pub-id-type="pmid">15476922</pub-id></element-citation></ref><ref id="bib58"><label>58</label><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Kerrigan</surname><given-names>A.M.</given-names></name><name><surname>Brown</surname><given-names>G.D.</given-names></name></person-group><article-title>C-type lectins and phagocytosis</article-title><source>Immunobiology</source><volume>214</volume><year>2009</year><fpage>562</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">19261355</pub-id></element-citation></ref><ref id="bib59"><label>59</label><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name><surname>Relloso</surname><given-names>M.</given-names></name><name><surname>Puig-Kr&#x000f6;ger</surname><given-names>A.</given-names></name><name><surname>Pello</surname><given-names>O.M.</given-names></name><name><surname>Rodr&#x000ed;guez-Fern&#x000e1;ndez</surname><given-names>J.L.</given-names></name><name><surname>de la Rosa</surname><given-names>G.</given-names></name><name><surname>Longo</surname><given-names>N.</given-names></name><name><surname>Navarro</surname><given-names>J.</given-names></name><name><surname>Mu&#x000f1;oz-Fern&#x000e1;ndez</surname><given-names>M.A.</given-names></name><name><surname>S&#x000e1;nchez-Mateos</surname><given-names>P.</given-names></name><name><surname>Corb&#x000ed;</surname><given-names>A.L.</given-names></name></person-group><article-title>DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents</article-title><source>J&#x000a0;Immunol</source><volume>168</volume><year>2002</year><fpage>2634</fpage><lpage>2643</lpage><pub-id pub-id-type="pmid">11884427</pub-id></element-citation></ref><ref id="bib60"><label>60</label><element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Ren</surname><given-names>S.</given-names></name><name><surname>Zuo</surname><given-names>Y.</given-names></name></person-group><article-title>DC-SIGN, DC-SIGNR and LSECtin: C-type lectins for infection</article-title><source>Int Rev Immunol</source><volume>33</volume><year>2014</year><fpage>54</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">24156700</pub-id></element-citation></ref><ref id="bib61"><label>61</label><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name><surname>Powlesland</surname><given-names>A.S.</given-names></name><name><surname>Ward</surname><given-names>E.M.</given-names></name><name><surname>Sadhu</surname><given-names>S.K.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Taylor</surname><given-names>M.E.</given-names></name><name><surname>Drickamer</surname><given-names>K.</given-names></name></person-group><article-title>Widely divergent biochemical properties of the complete set of mouse DC-SIGN-related proteins</article-title><source>J&#x000a0;Biol Chem</source><volume>281</volume><year>2006</year><fpage>20440</fpage><lpage>20449</lpage><pub-id pub-id-type="pmid">16682406</pub-id></element-citation></ref><ref id="bib62"><label>62</label><element-citation publication-type="journal" id="sref62"><person-group person-group-type="author"><name><surname>Park</surname><given-names>C.G.</given-names></name><name><surname>Takahara</surname><given-names>K.</given-names></name><name><surname>Umemoto</surname><given-names>E.</given-names></name><name><surname>Yashima</surname><given-names>Y.</given-names></name><name><surname>Matsubara</surname><given-names>K.</given-names></name><name><surname>Matsuda</surname><given-names>Y.</given-names></name><name><surname>Clausen</surname><given-names>B.E.</given-names></name><name><surname>Inaba</surname><given-names>K.</given-names></name><name><surname>Steinman</surname><given-names>R.M.</given-names></name></person-group><article-title>Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN</article-title><source>Int Immunol</source><volume>13</volume><year>2001</year><fpage>1283</fpage><lpage>1290</lpage><pub-id pub-id-type="pmid">11581173</pub-id></element-citation></ref><ref id="bib63"><label>63</label><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>Y.S.</given-names></name><name><surname>Do</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>H.K.</given-names></name><name><surname>Park</surname><given-names>S.H.</given-names></name><name><surname>Cheong</surname><given-names>C.</given-names></name><name><surname>Lynch</surname><given-names>R.M.</given-names></name><name><surname>Loeffler</surname><given-names>J.M.</given-names></name><name><surname>Steinman</surname><given-names>R.M.</given-names></name><name><surname>Park</surname><given-names>C.G.</given-names></name></person-group><article-title>A&#x000a0;dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q</article-title><source>Cell</source><volume>125</volume><year>2006</year><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">16615889</pub-id></element-citation></ref><ref id="bib64"><label>64</label><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name><surname>Lanoue</surname><given-names>A.</given-names></name><name><surname>Clatworthy</surname><given-names>M.R.</given-names></name><name><surname>Smith</surname><given-names>P.</given-names></name><name><surname>Green</surname><given-names>S.</given-names></name><name><surname>Townsend</surname><given-names>M.J.</given-names></name><name><surname>Jolin</surname><given-names>H.E.</given-names></name><name><surname>Smith</surname><given-names>K.G.</given-names></name><name><surname>Fallon</surname><given-names>P.G.</given-names></name><name><surname>McKenzie</surname><given-names>A.N.</given-names></name></person-group><article-title>SIGN-R1 contributes to protection against lethal pneumococcal infection in mice</article-title><source>J&#x000a0;Exp Med</source><volume>200</volume><year>2004</year><fpage>1383</fpage><lpage>1393</lpage><pub-id pub-id-type="pmid">15583012</pub-id></element-citation></ref><ref id="bib65"><label>65</label><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name><surname>Anthony</surname><given-names>R.M.</given-names></name><name><surname>Wermeling</surname><given-names>F.</given-names></name><name><surname>Karlsson</surname><given-names>M.C.</given-names></name><name><surname>Ravetch</surname><given-names>J.V.</given-names></name></person-group><article-title>Identification of a receptor required for the anti-inflammatory activity of IVIG</article-title><source>Proc Natl Acad Sci U S A</source><volume>105</volume><year>2008</year><fpage>19571</fpage><lpage>19578</lpage><pub-id pub-id-type="pmid">19036920</pub-id></element-citation></ref><ref id="bib66"><label>66</label><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name><surname>Chakraborty</surname><given-names>R.</given-names></name><name><surname>Chakraborty</surname><given-names>P.</given-names></name><name><surname>Basu</surname><given-names>M.K.</given-names></name></person-group><article-title>Macrophage mannosyl fucosyl receptor: its role in invasion of virulent and avirulent L. donovani promastigotes</article-title><source>Biosci Rep</source><volume>18</volume><year>1998</year><fpage>129</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">9798785</pub-id></element-citation></ref><ref id="bib67"><label>67</label><element-citation publication-type="journal" id="sref67"><person-group person-group-type="author"><name><surname>Kabha</surname><given-names>K.</given-names></name><name><surname>Nissimov</surname><given-names>L.</given-names></name><name><surname>Athamna</surname><given-names>A.</given-names></name><name><surname>Keisari</surname><given-names>Y.</given-names></name><name><surname>Parolis</surname><given-names>H.</given-names></name><name><surname>Parolis</surname><given-names>L.A.</given-names></name><name><surname>Grue</surname><given-names>R.M.</given-names></name><name><surname>Schlepper-Schafer</surname><given-names>J.</given-names></name><name><surname>Ezekowitz</surname><given-names>A.R.</given-names></name><name><surname>Ohman</surname><given-names>D.E.</given-names></name></person-group><article-title>Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae</article-title><source>Infect Immun</source><volume>63</volume><year>1995</year><fpage>847</fpage><lpage>852</lpage><pub-id pub-id-type="pmid">7868255</pub-id></element-citation></ref><ref id="bib68"><label>68</label><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name><surname>Kahn</surname><given-names>S.</given-names></name></person-group><article-title>Trypanosoma cruzi amastigote adhesion to macrophages is facilitated by the mannose receptor</article-title><source>J&#x000a0;Exp Med</source><volume>182</volume><year>1995</year><fpage>1243</fpage><lpage>1258</lpage><pub-id pub-id-type="pmid">7595195</pub-id></element-citation></ref><ref id="bib69"><label>69</label><element-citation publication-type="journal" id="sref69"><person-group person-group-type="author"><name><surname>Zamze</surname><given-names>S.</given-names></name><name><surname>Martinez-Pomares</surname><given-names>L.</given-names></name><name><surname>Jones</surname><given-names>H.</given-names></name><name><surname>Taylor</surname><given-names>P.R.</given-names></name><name><surname>Stillion</surname><given-names>R.J.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group><article-title>Recognition of bacterial capsular polysaccharides and lipopolysaccharides by the macrophage mannose receptor</article-title><source>J&#x000a0;Biol Chem</source><volume>277</volume><year>2002</year><fpage>41613</fpage><lpage>41623</lpage><pub-id pub-id-type="pmid">12196537</pub-id></element-citation></ref><ref id="bib70"><label>70</label><element-citation publication-type="journal" id="sref70"><person-group person-group-type="author"><name><surname>McGreal</surname><given-names>E.P.</given-names></name><name><surname>Miller</surname><given-names>J.L.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group><article-title>Ligand recognition by antigen-presenting cell C-type lectin receptors</article-title><source>Curr Opin Immunol</source><volume>17</volume><year>2005</year><fpage>18</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">15653305</pub-id></element-citation></ref><ref id="bib71"><label>71</label><element-citation publication-type="journal" id="sref71"><person-group person-group-type="author"><name><surname>den Brouw</surname><given-names>M.L.O.</given-names></name><name><surname>Binda</surname><given-names>R.S.</given-names></name><name><surname>Geijtenbeek</surname><given-names>T.B.H.</given-names></name><name><surname>Janssen</surname><given-names>H.L.</given-names></name><name><surname>Woltman</surname><given-names>A.M.</given-names></name></person-group><article-title>The mannose receptor acts as hepatitis B virus surface antigen receptor mediating interaction with intrahepatic dendritic cells</article-title><source>Virology</source><volume>393</volume><year>2009</year><fpage>84</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">19683778</pub-id></element-citation></ref><ref id="bib72"><label>72</label><element-citation publication-type="journal" id="sref72"><person-group person-group-type="author"><name><surname>Reading</surname><given-names>P.C.</given-names></name><name><surname>Miller</surname><given-names>J.L.</given-names></name><name><surname>Anders</surname><given-names>E.M.</given-names></name></person-group><article-title>Involvement of the mannose receptor in infection of macrophages by influenza virus</article-title><source>J&#x000a0;Virol</source><volume>74</volume><year>2000</year><fpage>5190</fpage><lpage>5197</lpage><pub-id pub-id-type="pmid">10799594</pub-id></element-citation></ref><ref id="bib73"><label>73</label><element-citation publication-type="journal" id="sref73"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>J.</given-names></name><name><surname>Bernhard</surname><given-names>O.K.</given-names></name><name><surname>Turville</surname><given-names>S.G.</given-names></name><name><surname>Harman</surname><given-names>A.N.</given-names></name><name><surname>Wilkinson</surname><given-names>J.</given-names></name><name><surname>Cunningham</surname><given-names>A.L.</given-names></name></person-group><article-title>Oligomerization of the macrophage mannose receptor enhances gp120-mediated binding of HIV-1</article-title><source>J&#x000a0;Biol Chem</source><volume>284</volume><year>2009</year><fpage>11027</fpage><lpage>11038</lpage><pub-id pub-id-type="pmid">19224860</pub-id></element-citation></ref><ref id="bib74"><label>74</label><element-citation publication-type="journal" id="sref74"><person-group person-group-type="author"><name><surname>Kogelberg</surname><given-names>H.</given-names></name><name><surname>Feizi</surname><given-names>T.</given-names></name></person-group><article-title>New structural insights into lectin-type proteins of the immune system</article-title><source>Curr Opin Struct Biol</source><volume>11</volume><year>2001</year><fpage>635</fpage><lpage>643</lpage><pub-id pub-id-type="pmid">11785767</pub-id></element-citation></ref><ref id="bib75"><label>75</label><element-citation publication-type="journal" id="sref75"><person-group person-group-type="author"><name><surname>Springer</surname><given-names>T.A.</given-names></name></person-group><article-title>Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm</article-title><source>Cell</source><volume>76</volume><year>1994</year><fpage>301</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">7507411</pub-id></element-citation></ref><ref id="bib76"><label>76</label><element-citation publication-type="journal" id="sref76"><person-group person-group-type="author"><name><surname>Kansas</surname><given-names>G.S.</given-names></name></person-group><article-title>Selectins and their ligands: current concepts and controversies</article-title><source>Blood</source><volume>88</volume><year>1996</year><fpage>3259</fpage><lpage>3287</lpage><pub-id pub-id-type="pmid">8896391</pub-id></element-citation></ref><ref id="bib77"><label>77</label><element-citation publication-type="journal" id="sref77"><person-group person-group-type="author"><name><surname>Pohlmann</surname><given-names>R.</given-names></name><name><surname>Boeker</surname><given-names>M.W.</given-names></name><name><surname>von Figura</surname><given-names>K.</given-names></name></person-group><article-title>The two mannose 6-phosphate receptors transport distinct complements of lysosomal proteins</article-title><source>J&#x000a0;Biol Chem</source><volume>270</volume><year>1995</year><fpage>27311</fpage><lpage>27318</lpage><pub-id pub-id-type="pmid">7592993</pub-id></element-citation></ref><ref id="bib78"><label>78</label><element-citation publication-type="journal" id="sref78"><person-group person-group-type="author"><name><surname>Arason</surname><given-names>G.J.</given-names></name></person-group><article-title>Lectins as defence molecules in vertebrates and invertebrates</article-title><source>Fish Shellfish Immunol</source><volume>6</volume><year>1966</year><fpage>277</fpage><lpage>289</lpage></element-citation></ref><ref id="bib79"><label>79</label><element-citation publication-type="journal" id="sref79"><person-group person-group-type="author"><name><surname>Dodd</surname><given-names>R.B.</given-names></name><name><surname>Drickamer</surname><given-names>K.</given-names></name></person-group><article-title>Lectin-like proteins in model organisms: implications for evolution of carbohydrate-binding activity</article-title><source>Glycobiology</source><volume>11</volume><year>2001</year><fpage>71R</fpage><lpage>79R</lpage></element-citation></ref><ref id="bib80"><label>80</label><element-citation publication-type="journal" id="sref80"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>A.F.</given-names></name></person-group><article-title>A&#x000a0;year in the life of the immunoglobulin superfamily</article-title><source>Immunol Today</source><volume>8</volume><year>1987</year><fpage>298</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">25290835</pub-id></element-citation></ref><ref id="bib81"><label>81</label><element-citation publication-type="journal" id="sref81"><person-group person-group-type="author"><name><surname>Angata</surname><given-names>T.</given-names></name><name><surname>Brinkman-Van der Linden</surname><given-names>E.</given-names></name></person-group><article-title>I-type lectins</article-title><source>Biochim Biophys Acta</source><volume>1572</volume><year>2002</year><fpage>294</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">12223277</pub-id></element-citation></ref><ref id="bib82"><label>82</label><element-citation publication-type="journal" id="sref82"><person-group person-group-type="author"><name><surname>Nauts</surname><given-names>H.C.</given-names></name><name><surname>Swift</surname><given-names>W.E.</given-names></name><name><surname>Coley</surname><given-names>B.L.</given-names></name></person-group><article-title>The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research</article-title><source>Cancer Res</source><volume>6</volume><year>1946</year><fpage>205</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">21018724</pub-id></element-citation></ref><ref id="bib83"><label>83</label><element-citation publication-type="book" id="sref83"><person-group person-group-type="author"><name><surname>Hamuro</surname><given-names>J.</given-names></name><name><surname>Chihara</surname><given-names>G.</given-names></name><name><surname>Lentinan</surname></name></person-group><chapter-title>a T-cell oriented immunopotentiator: its experimental and clinical applications and possible mechanism of immune modulation</chapter-title><person-group person-group-type="editor"><name><surname>Fenichel</surname><given-names>R.L.</given-names></name><name><surname>Chirigos</surname><given-names>M.A.</given-names></name></person-group><source>Immune modulation agents and their mechanisms</source><year>1984</year><publisher-name>Marcel Dekker</publisher-name><publisher-loc>New York</publisher-loc><fpage>409</fpage></element-citation></ref><ref id="bib84"><label>84</label><element-citation publication-type="journal" id="sref84"><person-group person-group-type="author"><name><surname>Wasser</surname><given-names>S.P.</given-names></name></person-group><article-title>Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides</article-title><source>Appl Microbiol Biotechnol</source><volume>60</volume><year>2002</year><fpage>258</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">12436306</pub-id></element-citation></ref><ref id="bib85"><label>85</label><element-citation publication-type="journal" id="sref85"><person-group person-group-type="author"><name><surname>Nergard</surname><given-names>C.S.</given-names></name><name><surname>Matsumoto</surname><given-names>T.</given-names></name><name><surname>Inngjerdingen</surname><given-names>M.</given-names></name><name><surname>Inngjerdingen</surname><given-names>K.</given-names></name><name><surname>Hokputsa</surname><given-names>S.</given-names></name><name><surname>Harding</surname><given-names>S.E.</given-names></name><name><surname>Michaelsen</surname><given-names>T.E.</given-names></name><name><surname>Diallo</surname><given-names>D.</given-names></name><name><surname>Kiyohara</surname><given-names>H.</given-names></name><name><surname>Paulsen</surname><given-names>B.S.</given-names></name></person-group><article-title>Structural and immunological studies of a pectin and a pectic arabinogalactan from Vernonia kotschyana Sch. Bip. ex Walp. (Asteraceae)</article-title><source>Carbohydr Res</source><volume>340</volume><year>2005</year><fpage>115</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">15620674</pub-id></element-citation></ref><ref id="bib86"><label>86</label><element-citation publication-type="journal" id="sref86"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>B.M.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Dai</surname><given-names>H.</given-names></name><name><surname>Tu</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Gao</surname><given-names>X.M.</given-names></name></person-group><article-title>A&#x000a0;study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb</article-title><source>Biochem Biophys Res Commun</source><volume>320</volume><year>2004</year><fpage>1103</fpage><lpage>1111</lpage><pub-id pub-id-type="pmid">15249203</pub-id></element-citation></ref><ref id="bib87"><label>87</label><element-citation publication-type="journal" id="sref87"><person-group person-group-type="author"><name><surname>Schepetkin</surname><given-names>I.A.</given-names></name><name><surname>Quinn</surname><given-names>M.T.</given-names></name></person-group><article-title>Botanical polysaccharides: macrophage immunomodulation and therapeutic potential</article-title><source>Int Immunopharmacol</source><volume>6</volume><year>2006</year><fpage>317</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">16428067</pub-id></element-citation></ref><ref id="bib88"><label>88</label><element-citation publication-type="journal" id="sref88"><person-group person-group-type="author"><name><surname>El Enshasy</surname><given-names>H.A.</given-names></name><name><surname>Hatti-Kaul</surname><given-names>R.</given-names></name></person-group><article-title>Mushroom immunomodulators: unique molecules with unlimited applications</article-title><source>Trends Biotechnol</source><volume>31</volume><year>2013</year><fpage>668</fpage><lpage>677</lpage><pub-id pub-id-type="pmid">24125745</pub-id></element-citation></ref><ref id="bib89"><label>89</label><element-citation publication-type="journal" id="sref89"><person-group person-group-type="author"><name><surname>Ramberg</surname><given-names>J.E.</given-names></name><name><surname>Nelson</surname><given-names>E.D.</given-names></name><name><surname>Sinnott</surname><given-names>R.A.</given-names></name></person-group><article-title>Immunomodulatory dietary polysaccharides: a systematic review of the literature</article-title><source>Nutr J</source><volume>9</volume><year>2010</year><fpage>54</fpage><pub-id pub-id-type="pmid">21087484</pub-id></element-citation></ref><ref id="bib90"><label>90</label><element-citation publication-type="journal" id="sref90"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>W.T.</given-names></name><name><surname>Lai</surname><given-names>T.H.</given-names></name><name><surname>Chyan</surname><given-names>Y.J.</given-names></name><name><surname>Yin</surname><given-names>S.Y.</given-names></name><name><surname>Chen</surname><given-names>Y.H.</given-names></name><name><surname>Wei</surname><given-names>W.C.</given-names></name><name><surname>Yang</surname><given-names>N.S.</given-names></name></person-group><article-title>Specific medicinal plant polysaccharides effectively enhance the potency of a DC-based vaccine against mouse mammary tumor metastasis</article-title><source>PLoS One</source><volume>10</volume><year>2015</year><fpage>e0122374</fpage><pub-id pub-id-type="pmid">25825910</pub-id></element-citation></ref><ref id="bib91"><label>91</label><mixed-citation publication-type="other" id="oref1">Yeon-Sook Yun, Jie-Young Song, In-Sung Jung, investors; Korea Institute of Radiological &#x00026; Medical Sciences, assignee. Composition comprising polysaccharide extracted from <italic>Panax ginseng</italic> preventing and treating liver diseases. US patent 20110046086. February 24, 2011.</mixed-citation></ref><ref id="bib92"><label>92</label><element-citation publication-type="journal" id="sref92"><person-group person-group-type="author"><name><surname>Vasta</surname><given-names>G.R.</given-names></name><name><surname>Ahmed</surname><given-names>H.</given-names></name><name><surname>Bianchet</surname><given-names>M.A.</given-names></name><name><surname>Fern&#x000e1;ndez-Robledo</surname><given-names>J.A.</given-names></name><name><surname>Amzel</surname><given-names>L.M.</given-names></name></person-group><article-title>Diversity in recognition of glycans by F-type lectins and galectins: molecular, structural, and biophysical aspects</article-title><source>Ann N Y Acad Sci</source><volume>1253</volume><year>2012</year><fpage>E14</fpage><lpage>E26</lpage><pub-id pub-id-type="pmid">22973821</pub-id></element-citation></ref><ref id="bib93"><label>93</label><element-citation publication-type="journal" id="sref93"><person-group person-group-type="author"><name><surname>Weis</surname><given-names>W.I.</given-names></name><name><surname>Drickamer</surname><given-names>K.</given-names></name></person-group><article-title>Structural basis of lectin-carbohydrate recognition</article-title><source>Annu Rev Biochem</source><volume>65</volume><year>1996</year><fpage>441</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">8811186</pub-id></element-citation></ref><ref id="bib94"><label>94</label><element-citation publication-type="journal" id="sref94"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>M.</given-names></name><name><surname>Schorey</surname><given-names>J.S.</given-names></name></person-group><article-title>The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria</article-title><source>Blood</source><volume>108</volume><year>2006</year><fpage>3168</fpage><lpage>3175</lpage><pub-id pub-id-type="pmid">16825490</pub-id></element-citation></ref><ref id="bib95"><label>95</label><element-citation publication-type="journal" id="sref95"><person-group person-group-type="author"><name><surname>Byeon</surname><given-names>S.E.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Kwak</surname><given-names>Y.S.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choung</surname><given-names>E.S.</given-names></name><name><surname>Rhee</surname><given-names>M.H.</given-names></name><name><surname>Cho</surname><given-names>J.Y.</given-names></name></person-group><article-title>Molecular mechanism of macrophage activation by red ginseng acidic polysaccharide from Korean red ginseng</article-title><source>Mediators Inflamm</source><volume>2012</volume><year>2012</year><fpage>732860</fpage><pub-id pub-id-type="pmid">22474399</pub-id></element-citation></ref></ref-list><ack id="ack0010"><title>Acknowledgements</title><p>This paper was supported by Konkuk University in 2012.</p></ack></back><floats-group><fig id="fig1"><label>Fig.&#x000a0;1</label><caption><p>The structure, cellular distribution, and reactive immune components of animal lectins. Domain structure models, the location of several representative animal lectins, and the immune cells reacting with animal lectins. Carbohydrate-recognition domains (CRDs) of each lectin are depicted in the respective whole structures. S-type lectins are secreted into the extracellular matrix of body fluids. C-type and I-type lectins are localized to the plasma membrane, and P-type lectins are located in luminal compartments of the secretory pathway. CD-MPR, cation-dependent mannose-6-phosphate receptor; CI-MPR, cation-independent mannose-6-phosphate receptor; CRD, carbohydrate-recognition domain; DC, dendritic cell; DC-SIGN, DC-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin; IGF, insulin-like growth factor; MRH Man-6P, mannose 6-phosphate receptor homology; ITIM/ITAM motif, immunoreceptor tyrosine-based inhibition/immunoreceptor tyrosine-based activation motif.</p></caption><graphic xlink:href="gr1"/></fig><table-wrap id="tbl1" position="float"><label>Table&#x000a0;1</label><caption><p>The classification of lectins based on structure of carbohydrate-recognition domain (CRD)</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Lectin</th><th rowspan="2">Expressed cell types</th><th rowspan="2">Ligands</th><th rowspan="2">Location</th><th rowspan="2">Role</th><th rowspan="2">Example</th><th colspan="3">Species<hr/></th></tr><tr><th>Human</th><th>Mouse</th><th>Plant</th></tr></thead><tbody><tr><td>C-type lectin</td><td>DC<sup>a</sup>, M&#x000f8;<sup>b</sup>, LC<sup>c</sup>, Mo<sup>d</sup>, T<sup>e</sup></td><td>Various (mannose, fucose, &#x003b2;-glucan, glucosamine)</td><td>Extracellular, transmembrane</td><td>Recognition of pathogens, clearance, endocytosis, adhesion, immune-modulation</td><td>MR, DC-SIGN, SIGN-Rs, Dectin, Selectin</td><td>&#x0039f;</td><td>&#x0039f;</td><td>&#x0039f;</td></tr><tr><td>P-type lectin</td><td>Eukaryotic cells</td><td>Man-6-phosphate</td><td>Secretory pathway, endosome</td><td>Endocytosis, intracellular targeting of lysosomal enzymes (lysosome biogenesis)</td><td>CD-MPR, IGF-II/CI-MPR</td><td>&#x0039f;</td><td>&#x0039f;</td><td>&#x003a7;</td></tr><tr><td>S-type lectin</td><td/><td>&#x003b2;-galactoside</td><td>Secrete (cytoplasm), extracellular</td><td>Cell adhesion, growth regulation, cell migration, immune responses</td><td>Galectin (1-14)</td><td>&#x0039f;</td><td>&#x0039f;</td><td>&#x003a7;</td></tr><tr><td>I-type lectin</td><td>Mast, Bf, M&#x000f8;, Mo</td><td>Sialic acid</td><td>Membrane</td><td>Regulation of myeloid cell inter-action, differentiation of myeloid cells, adhesion, signaling</td><td>Siglecs (CD33-related subgroup, sialoadhesin, CD22 and MAG)</td><td>&#x0039f;</td><td>&#x0039f;</td><td>&#x003a7;</td></tr><tr><td>M-type lectin</td><td/><td>Mannose glycan</td><td>Endoplasmic reticulum</td><td>&#x003b1;-Mannosidase, handling of N-linked glycoproteins</td><td>EDEM1, EDEM2 and EDEM3</td><td>&#x0039f;</td><td>&#x0039f;</td><td>&#x0039f;</td></tr><tr><td>L-type lectin</td><td/><td>High-mannose Glycan</td><td>Intracellular, Golgi, endoplasmic reticulum, ERGIC<sup>g</sup></td><td>Protein sorting, assisting secretion of specific glycoproteins</td><td>ERGIC-53, ERGL, VIP36, and VIPL</td><td>&#x0039f;</td><td>&#x0039f;</td><td>&#x0039f;</td></tr><tr><td>Chitinase-like lectin</td><td>Neutrophil, M&#x000f8;, epithelial cell</td><td>Chito-oligosaccharide</td><td>Extracellular</td><td>Collagen metabolism</td><td>YKL-40, Ym1, Oviduction</td><td>&#x0039f;</td><td>&#x0039f;</td><td>&#x0039f;</td></tr><tr><td>F-type lectin</td><td/><td>Fucose-terminating oligosaccharide</td><td>Extracellular</td><td>Innate immunity</td><td>Fucolectins</td><td>&#x003a7;</td><td>&#x003a7;</td><td>&#x003a7;</td></tr></tbody></table><table-wrap-foot><fn><p>B, B cell; DCs, dendritic cells; dM&#x000f8;, decidual macrophage; ERGIC, ER-Golgi intermediate compartment; LC, Langerhans cell; M&#x000f8;, macrophage; Mo, monocyte; T, T cell</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2" position="float"><label>Table&#x000a0;2</label><caption><p>A summary of the C-type lectin receptors dealt with in this review</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Lectin</th><th rowspan="2">Expressed cell types</th><th rowspan="2">Ligands</th><th rowspan="2">Pathogens</th><th colspan="3">Species<hr/></th></tr><tr><th>Human</th><th>Mouse</th><th>Plant</th></tr></thead><tbody><tr><td>MR</td><td>M&#x000f8;<sup>a</sup>, DC<sup>b</sup> subset, Lymphatic and hepatic endothelium</td><td>Mannose, Fucose, N-acetyl glucosamine, Sulphated sugar</td><td>Yeast, bacteria, HIV<sup>n</sup>, C. <italic>albicans, L. donovani, P. carinii, Klebsiella pneumonia, Trypanosoma cruzi, M. tuberculosis</italic>, capsular polysaccharides of S. pneumoniae</td><td>&#x0039f;</td><td>&#x0039f;</td><td>&#x0039f;</td></tr><tr><td>DC-SIGN</td><td>DC, dM&#x000f8;<sup>c</sup>, aM&#x000f8;<sup>d</sup></td><td>Mannose type CRD, Mannan, ManLam, ICAM-2, ICAM-3</td><td>HIV, <italic>Mycobacterium tuberculosis, C. albicans, Leishmania mexicana, A. fumigatus, Helicobacter pylori, Schistosoma mansoni</italic></td><td>&#x0039f;</td><td>&#x003a7;</td><td>&#x003a7;</td></tr><tr><td>SIGN-R1</td><td>MZ M&#x000f8;<sup>e</sup>, pM&#x000f8;<sup>f</sup></td><td>Mannose type CRD, Dextran, ICAM-3</td><td><italic>C. albicans, M. tuberculosis, S. pneumoniae</italic>, CPS, HIV, yeast-derived zymosan particles</td><td>&#x003a7;</td><td>&#x0039f;</td><td>&#x003a7;</td></tr><tr><td>Dectin-1</td><td>DC, LC<sup>g</sup>, M&#x000f8;, PMN<sup>h</sup></td><td>&#x003b2;-glucan, T-cell ligand</td><td><italic>C. albicans, Saccharomyces cerevisiae</italic>, <italic>Coccidioides posadasii, Pneumocystis carinii</italic></td><td>&#x0039f;</td><td>&#x0039f;</td><td>&#x003a7;</td></tr><tr><td>Dectin-2</td><td>H: Mo<sup>i</sup>, B<sup>j</sup>, Activated CD4+ T<sup>k</sup> M: M&#x000f8;, PMN, LC</td><td>Mannose type ligands, CD4/CD25+ T-cell ligand</td><td><italic>C. Albicans</italic></td><td>&#x0039f;</td><td>&#x0039f;</td><td>&#x003a7;</td></tr><tr><td>L-selectin</td><td>Leukocyte</td><td>s6SLex <sup>l</sup></td><td>Arenavirus, Hantavirus, Coronavirus, Filovirus, Orthomyxovirus</td><td>&#x0039f;</td><td>&#x0039f;</td><td>&#x003a7;</td></tr><tr><td>P-selectin</td><td>Platelets, Endothelium</td><td>sLe<sup>x</sup><sup>m</sup>, s6SLex</td><td>HSV<sup>o</sup>, VZV<sup>p</sup></td><td>&#x0039f;</td><td>&#x0039f;</td><td>&#x003a7;</td></tr><tr><td>E-selectin</td><td>Activated endothelium</td><td>sLe<sup>x</sup>, s6SLe<sup>x</sup></td><td><italic>Porphyromonas gingivalis</italic></td><td>&#x0039f;</td><td>&#x0039f;</td><td>&#x003a7;</td></tr></tbody></table><table-wrap-foot><fn><p>aM&#x000f8;, alveolar macrophage; B, B cell; DCs, dendritic cells; dM&#x000f8;, decidual macrophage; HIV, Human immunodeficiency virus; HSV, Herpes simplex virus; LC, Langerhans cell; M&#x000f8;, macrophage; Mo, monocyte; MZ M&#x000f8;, marginal zone macrophage; pM&#x000f8;, peritoneal macrophage; PMN, polymorphonuclear cell; s6SLe<sup>x</sup>, sialyl 6-sulpho Lewis<sup>x</sup>; sLe<sup>x</sup>, sialyl Lewis<sup>x</sup>; T, T cell; VZV, Varicella zoster virus</p></fn></table-wrap-foot></table-wrap></floats-group></article>